label,type,title,author,journal,abstract,year,doi,volume,issue,pages,language,issn,keywords,url,institution,DA,j2,DP,l1,l2,ST
Sanchez.Pinto_2018_Ches,JOUR,Big Data and Data Science in Critical Care,"Sanchez-Pinto, L. Nelson and Luo, Yuan and Churpek, Matthew M.",Chest,"The digitalization of the health-care system has resulted in a deluge of clinical big data and has prompted the rapid growth of data science in medicine. Data science, which is the field of study dedicated to the principled extraction of knowledge from complex data, is particularly relevant in the critical care setting. The availability of large amounts of data in the ICU, the need for better evidence-based care, and the complexity of critical illness makes the use of data science techniques and data-driven research particularly appealing to intensivists. Despite the increasing number of studies and publications in the field, thus far there have been few examples of data science projects that have resulted in successful implementations of data-driven systems in the ICU. However, given the expected growth in the field, intensivists should be familiar with the opportunities and challenges of big data and data science. The present article reviews the definitions, types of algorithms, applications, challenges, and future of big data and data science in critical care.",2018,10.1016/j.chest.2018.04.037,154,5,1239-1248,eng,1931-3543 0012-3692,machine learning and data science and Humans and Forecasting and big data and *Big Data and Data Science/*methods and critical care and prediction models and *Critical Care/methods/organization & administration and *Delivery of Health Care/methods/trends,NA,NA,2018/11//undefined,Chest,NA,NA,NA,NA
Meyer_2018_TheLanResmed,JOUR,Machine learning for real-time prediction of complications in critical care: a retrospective study,"Meyer, Alexander and Zverinski, Dina and Pfahringer, Boris and Kempfert, Jorg and Kuehne, Titus and Sundermann, Simon H. and Stamm, Christof and Hofmann, Thomas and Falk, Volkmar and Eickhoff, Carsten",The Lancet. Respiratory medicine,"BACKGROUND: The large amount of clinical signals in intensive care units can easily overwhelm health-care personnel and can lead to treatment delays, suboptimal care, or clinical errors. The aim of this study was to apply deep machine learning methods to predict severe complications during critical care in real time after cardiothoracic surgery. METHODS: We used deep learning methods (recurrent neural networks) to predict several severe complications (mortality, renal failure with a need for renal replacement therapy, and postoperative bleeding leading to operative revision) in post cardiosurgical care in real time. Adult patients who underwent major open heart surgery from Jan 1, 2000, to Dec 31, 2016, in a German tertiary care centre for cardiovascular diseases formed the main derivation dataset. We measured the accuracy and timeliness of the deep learning model's forecasts and compared predictive quality to that of established standard-of-care clinical reference tools (clinical rule for postoperative bleeding, Simplified Acute Physiology Score II for mortality, and the Kidney Disease: Improving Global Outcomes staging criteria for acute renal failure) using positive predictive value (PPV), negative predictive value, sensitivity, specificity, area under the curve (AUC), and the F(1) measure (which computes a harmonic mean of sensitivity and PPV). Results were externally retrospectively validated with 5898 cases from the published MIMIC-III dataset. FINDINGS: Of 47 559 intensive care admissions (corresponding to 42 007 patients), we included 11 492 (corresponding to 9269 patients). The deep learning models yielded accurate predictions with the following PPV and sensitivity scores: PPV 0<c2><b7>90 and sensitivity 0<c2><b7>85 for mortality, 0<c2><b7>87 and 0<c2><b7>94 for renal failure, and 0<c2><b7>84 and 0<c2><b7>74 for bleeding. The predictions significantly outperformed the standard clinical reference tools, improving the absolute complication prediction AUC by 0<c2><b7>29 (95% CI 0<c2><b7>23-0<c2><b7>35) for bleeding, by 0<c2><b7>24 (0<c2><b7>19-0<c2><b7>29) for mortality, and by 0<c2><b7>24 (0<c2><b7>13-0<c2><b7>35) for renal failure (p<0<c2><b7>0001 for all three analyses). The deep learning methods showed accurate predictions immediately after patient admission to the intensive care unit. We also observed an increase in performance in our validation cohort when the machine learning approach was tested against clinical reference tools, with absolute improvements in AUC of 0<c2><b7>09 (95% CI 0<c2><b7>03-0<c2><b7>15; p=0<c2><b7>0026) for bleeding, of 0<c2><b7>18 (0<c2><b7>07-0<c2><b7>29; p=0<c2><b7>0013) for mortality, and of 0<c2><b7>25 (0<c2><b7>18-0<c2><b7>32; p<0<c2><b7>0001) for renal failure. INTERPRETATION: The observed improvements in prediction for all three investigated clinical outcomes have the potential to improve critical care. These findings are noteworthy in that they use routinely collected clinical data exclusively, without the need for any manual processing. The deep machine learning method showed AUC scores that significantly surpass those of clinical reference tools, especially soon after admission. Taken together, these properties are encouraging for prospective deployment in critical care settings to direct the staff's attention towards patients who are most at risk. FUNDING: No specific funding.",2018,10.1016/S2213-2600(18)30300-X,6,12,905-914,eng,2213-2619 2213-2600,"Humans and Female and Male and Middle Aged and Retrospective Studies and Aged and Predictive Value of Tests and ROC Curve and Outcome Assessment, Health Care and Intensive Care Units/statistics & numerical data and *Deep Learning and Cardiac Surgical Procedures/*adverse effects/mortality and Postoperative Hemorrhage/*diagnosis/epidemiology and Renal Insufficiency/*diagnosis/epidemiology",NA,NA,2018/12//undefined,Lancet Respir Med,NA,NA,NA,NA
Walsh_2020_TheLanResmed,JOUR,Imaging research in fibrotic lung disease; applying deep learning to unsolved problems,"Walsh, Simon L. F. and Humphries, Stephen M. and Wells, Athol U. and Brown, Kevin K.",The Lancet. Respiratory medicine,"Over the past decade, there has been a groundswell of research interest in computer-based methods for objectively quantifying fibrotic lung disease on high resolution CT of the chest. In the past 5 years, the arrival of deep learning-based image analysis has created exciting new opportunities for enhancing the understanding of, and the ability to interpret, fibrotic lung disease on CT. Specific unsolved problems for which computer-based imaging analysis might provide solutions include the development of reliable methods for assisting with diagnosis, detecting early disease, and predicting disease behaviour using baseline imaging data. However, to harness this technology, technical and societal challenges must be overcome. Large CT datasets will be needed to power the training of deep learning algorithms. Open science research and collaboration between academia and industry must be encouraged. Prospective clinical utility studies will be needed to test computer algorithm performance in real-world clinical settings and demonstrate patient benefit over current best practice. Finally, ethical standards, which ensure patient confidentiality and mitigate against biases in training datasets, that can be encoded in machine-learning systems will be needed as well as bespoke data governance and accountability frameworks to encourage buy-in from health-care professionals, patients, and the public.",2020,10.1016/S2213-2600(20)30003-5,8,11,1144-1153,eng,2213-2619 2213-2600,"Humans and Female and Male and Retrospective Studies and Forecasting and Machine Learning and Databases, Factual and Cohort Studies and Tomography, X-Ray Computed/*methods and Deep Learning/*trends and *Image Interpretation, Computer-Assisted and Pulmonary Fibrosis/*diagnostic imaging/pathology and Radiography, Thoracic/methods/*trends",NA,NA,2020/11//undefined,Lancet Respir Med,NA,NA,NA,NA
Saglani_2019_Amjoofreancrcame,JOUR,Childhood Asthma: Advances Using Machine Learning and Mechanistic Studies,"Saglani, Sejal and Custovic, Adnan",American journal of respiratory and critical care medicine,"A paradigm shift brought by the recognition that childhood asthma is an aggregated diagnosis that comprises several different endotypes underpinned by different pathophysiology, coupled with advances in understanding potentially important causal mechanisms, offers a real opportunity for a step change to reduce the burden of the disease on individual children, families, and society. Data-driven methodologies facilitate the discovery of ""hidden"" structures within ""big healthcare data"" to help generate new hypotheses. These findings can be translated into clinical practice by linking discovered ""phenotypes"" to specific mechanisms and clinical presentations. Epidemiological studies have provided important clues about mechanistic avenues that should be pursued to identify interventions to prevent the development or alter the natural history of asthma-related diseases. Findings from cohort studies followed by mechanistic studies in humans and in neonatal mouse models provided evidence that environments such as traditional farming may offer protection by modulating innate immune responses and that impaired innate immunity may increase susceptibility. The key question of which component of these exposures can be translated into interventions requires confirmation. Increasing mechanistic evidence is demonstrating that shaping the microbiome in early life may modulate immune function to confer protection. Iterative dialogue and continuous interaction between experts with different but complementary skill sets, including data scientists who generate information about the hidden structures within ""big data"" assets, and medical professionals, epidemiologists, basic scientists, and geneticists who provide critical clinical and mechanistic insights about the mechanisms underpinning the architecture of the heterogeneity, are keys to delivering mechanism-based stratified treatments and prevention.",2019,10.1164/rccm.201810-1956CI,199,4,414-422,eng,1535-4970 1073-449X,"machine learning and Humans and Child and Big Data and children and Models, Biological and *Machine Learning and asthma mechanism and Asthma/*diagnosis/etiology/prevention & control and Immunity, Innate",NA,NA,2019/02/15/,Am J Respir Crit Care Med,NA,NA,NA,NA
Almaaitah_2020_Ches,JOUR,Variation in Patient Smoking Cessation Rates Among Health-Care Providers: An Observational Study,"Almaaitah, Saja and Ciemins, Elizabeth L. and Joshi, Vaishali and Arora, Anupama and Meskow, Christopher and Rothberg, Michael B.",Chest,"BACKGROUND: Physicians play a crucial role in providing smoking cessation counseling and medications. However, it is unknown whether individual physicians' approaches affect whether patients quit. RESEARCH QUESTION: This study assessed patient quit rates within a national quality-improvement learning collaborative to document variation in quit rates at the physician, practice, and health system levels. STUDY DESIGN AND METHODS: A retrospective cohort study was conducted of primary care patients identified from the Optum analytics database containing longitudinal ambulatory data for patients from 22 health-care organizations between January 2012 and December 2018. The study included smokers aged <e2><89><a5> 18 years who attended at least three ambulatory visits, with two visits at least 1 year apart. The primary study outcome was abstinence for <e2><89><a5> 1 year. A mixed effects logistic regression model was used to predict the probability of quitting as a function of patient variables. Quit rates were then adjusted by patient factors and calculated at the level of clinician, clinic/practice, and health system. RESULTS: Across all systems, 56% of patients had a documented smoking status in 2017. Among nearly 1 million smokers, 24% quit smoking. In the regression model, patient characteristics associated with quitting included older age, Hispanic ethnicity, being married, urban residence, commercial insurance, pregnancy, and a diagnosis of pneumonia, myocardial infarction, ischemic heart disease, cataract, or asthma. Medicaid insurance, low income, high BMI, peripheral vascular disease, alcohol-related diagnosis, and COPD were negatively associated with smoking cessation. Adjusted quit rates ranged from 14.3% to 34.5% across 20 health systems, 5% to 66% among 1,399 practice sites, and 4% to 87% among 3,803 health-care providers. Of smokers, 10.2% were prescribed smoking deterrents, and 3.9% were referred for counseling. INTERPRETATION: Smoking cessation rates varied substantially at the practitioner, practice site, and health system levels. It is likely that individual physician approaches to smoking cessation influence patients' likelihood of quitting.",2020,10.1016/j.chest.2020.05.599,158,5,2038-2046,eng,1931-3543 0012-3692,Humans and Female and Male and Middle Aged and Retrospective Studies and Incidence and United States/epidemiology and smoking cessation and Health Personnel/*statistics & numerical data and Counseling/*methods and health-care providers and Smoking Cessation/*statistics & numerical data and Smoking/*adverse effects/epidemiology and variation,NA,NA,2020/11//undefined,Chest,NA,NA,NA,NA
Shashikumar_2021_Ches,JOUR,Development and Prospective Validation of a Deep Learning Algorithm for Predicting Need for Mechanical Ventilation,"Shashikumar, Supreeth P. and Wardi, Gabriel and Paul, Paulina and Carlile, Morgan and Brenner, Laura N. and Hibbert, Kathryn A. and North, Crystal M. and Mukerji, Shibani S. and Robbins, Gregory K. and Shao, Yu-Ping and Westover, M. Brandon and Nemati, Shamim and Malhotra, Atul",Chest,"BACKGROUND: Objective and early identification of hospitalized patients, and particularly those with novel coronavirus disease 2019 (COVID-19), who may require mechanical ventilation (MV) may aid in delivering timely treatment. RESEARCH QUESTION: Can a transparent deep learning (DL) model predict the need for MV in hospitalized patients and those with COVID-19 up to 24 h in advance? STUDY DESIGN AND METHODS: We trained and externally validated a transparent DL algorithm to predict the future need for MV in hospitalized patients, including those with COVID-19, using commonly available data in electronic health records. Additionally, commonly used clinical criteria (heart rate, oxygen saturation, respiratory rate, Fio(2), and pH) were used to assess future need for MV. Performance of the algorithm was evaluated using the area under receiver operating characteristic curve (AUC), sensitivity, specificity, and positive predictive value. RESULTS: We obtained data from more than 30,000 ICU patients (including more than 700 patients with COVID-19) from two academic medical centers. The performance of the model with a 24-h prediction horizon at the development and validation sites was comparable (AUC, 0.895 vs 0.882, respectively), providing significant improvement over traditional clinical criteria (P < .001). Prospective validation of the algorithm among patients with COVID-19 yielded AUCs in the range of 0.918 to 0.943. INTERPRETATION: A transparent deep learning algorithm improves on traditional clinical criteria to predict the need for MV in hospitalized patients, including in those with COVID-19. Such an algorithm may help clinicians to optimize timing of tracheal intubation, to allocate resources and staff better, and to improve patient care.",2021,10.1016/j.chest.2020.12.009,159,6,2264-2273,eng,1931-3543 0012-3692,"deep learning and artificial intelligence and Hospitalization and Humans and Female and Male and Middle Aged and Aged and Prospective Studies and Predictive Value of Tests and ROC Curve and Critical Care and coronavirus and *Respiration, Artificial and *Deep Learning and *Health Services Needs and Demand and artificial respiration and COVID-19/*complications/*therapy and Intubation, Intratracheal and lung",NA,NA,2021/06//undefined,Chest,NA,NA,NA,NA
Pifferi_2011_Ches,JOUR,Monitoring asthma control in children with allergies by soft computing of lung function and exhaled nitric oxide,"Pifferi, Massimo and Bush, Andrew and Pioggia, Giovanni and Di Cicco, Maria and Chinellato, Iolanda and Bodini, Alessandro and Macchia, Pierantonio and Boner, Attilio L.",Chest,"BACKGROUND: Asthma control is emphasized by new guidelines but remains poor in many children. Evaluation of control relies on subjective patient recall and may be overestimated by health-care professionals. This study assessed the value of spirometry and fractional exhaled nitric oxide (FeNO) measurements, used alone or in combination, in models developed by a machine learning approach in the objective classification of asthma control according to Global Initiative for Asthma guidelines and tested the model in a second group of children with asthma. METHODS: Fifty-three children with persistent atopic asthma underwent two to six evaluations of asthma control, including spirometry and FeNO. Soft computing evaluation was performed by means of artificial neural networks and principal component analysis. The model was then tested in a cross-sectional study in an additional 77 children with allergic asthma. RESULTS: The machine learning method was not able to distinguish different levels of control using either spirometry or FeNO values alone. However, their use in combination modeled by soft computing was able to discriminate levels of asthma control. In particular, the model is able to recognize all children with uncontrolled asthma and correctly identify 99.0% of children with totally controlled asthma. In the cross-sectional study, the model prospectively identified correctly all the uncontrolled children and 79.6% of the controlled children. CONCLUSIONS: Soft computing analysis of spirometry and FeNO allows objective categorization of asthma control status.",2011,10.1378/chest.10-0992,139,2,319-327,eng,1931-3543 0012-3692,"Humans and Female and Male and Adolescent and Child and Cross-Sectional Studies and Longitudinal Studies and Prospective Studies and Predictive Value of Tests and Severity of Illness Index and Statistics, Nonparametric and *Neural Networks, Computer and Asthma/drug therapy/*physiopathology and Breath Tests/*methods and Exhalation and Nitric Oxide/*metabolism and Spirometry",NA,NA,2011/02//undefined,Chest,NA,NA,NA,NA
Carroll_2017_Ches,JOUR,"Building Community Through a #pulmcc Twitter Chat to Advocate for Pulmonary, Critical Care, and Sleep","Carroll, Christopher L. and Bruno, Kristi and Ramachandran, Pradeep",Chest,"BACKGROUND: Social media sites such as Twitter can significantly enhance education and advocacy efforts. In 2013, the American College of Chest Physicians (CHEST) launched a Twitter chat series using the hashtag #pulmcc to educate and advocate for topics related to pulmonary, critical care, and sleep medicine. METHODS: To assess the reach of these chats, we analyzed the metrics using Symplur analytics, and compared data from each chat, as well as participant data. RESULTS: Since December 19, 2013, there have been 12 Twitter chats: six have been on critical care-related topics, four have been on pulmonary-/sleep-related topics, and two have been conducted during the CHEST annual meeting on more general topics. During these 1-h Twitter chats, there were a total of 4,212 tweets by 418 participants, resulting in 9,361,519 impressions (ie, views). There were similar numbers of participants and tweets in the three categories of Twitter chats, but there was a significantly greater reach during the more general Twitter chats conducted at the CHEST annual meeting, with 1,596,013 <c2><b1> 126,472 impressions per chat session at these chats, compared with 739,203 <c2><b1> 73,109 impressions per chat session during the critical care Twitter chats and 621,965 <c2><b1> 123,933 impressions per chat session in the pulmonary/sleep chats. Seventy-five participants participated in two or more #pulmcc Twitter chats, and the average percent of return participants in each chat was 30% <c2><b1> 7%. Most of the return participants were health-care providers. CONCLUSIONS: Twitter chats can be a powerful tool for the widespread engagement of a medical audience.",2017,10.1016/j.chest.2017.03.003,152,2,402-409,eng,1931-3543 0012-3692,medical informatics and education and Humans and Social Media/*statistics & numerical data and critical care and Critical Care/*statistics & numerical data and *Sleep and Medical Informatics/statistics & numerical data and pulmonary and Pulmonary Medicine/education/*statistics & numerical data and sleep medicine,NA,NA,2017/08//undefined,Chest,NA,NA,NA,NA
Murphy_2016_Ches,JOUR,Computerized Triggers of Big Data to Detect Delays in Follow-up of Chest Imaging Results,"Murphy, Daniel R. and Meyer, Ashley N. D. and Bhise, Viraj and Russo, Elise and Sittig, Dean F. and Wei, Li and Wu, Louis and Singh, Hardeep",Chest,"BACKGROUND: A ""trigger"" algorithm was used to identify delays in follow-up of abnormal chest imaging results in a large national clinical data warehouse of electronic health record (EHR) data. METHODS: We applied a trigger in a repository hosting EHR data from all Department of Veterans Affairs health-care facilities and analyzed data from seven facilities. Using literature reviews and expert input, we refined previously developed trigger criteria designed to identify patients potentially experiencing delays in diagnostic evaluation of chest imaging flagged as ""suspicious for malignancy."" The trigger then excluded patients in whom further evaluation was unnecessary (eg, those with terminal illnesses or with already completed biopsies). The criteria were programmed into a computerized algorithm. Reviewers examined a random sample of trigger-positive (ie, patients with trigger-identified delay) and trigger-negative (ie, patients with an abnormal imaging result but no delay) records and confirmed the presence or absence of delay or need for additional tracking (eg, repeat imaging in 6 months). Analysis included calculating the trigger's diagnostic performance (ie, positive predictive value, negative predictive value, sensitivity, specificity). RESULTS: On application to 208,633 patients seen between January 1, 2012, and December 31, 2012, a total of 40,218 chest imaging tests were performed; 1,847 of the results were suspicious for malignancy, and 655 (35%) were trigger-positive. Review of 400 randomly selected trigger-positive patients found 158 (40%) with confirmed delays and 84 (21%) requiring additional tracking (positive predictive value, 61% [95% CI, 55.5-65.3]). Review of 100 trigger-negative patients identified 97 without delay (negative predictive value, 97%; [95% CI, 90.8-99.2]). Sensitivity and specificity were 99% (95% CI, 96.2-99.7) and 38% (95% CI, 32.1-44.3), respectively. CONCLUSIONS: Application of triggers on ""big"" EHR data may aid in identifying patients experiencing delays in diagnostic evaluation of chest imaging results suspicious for malignancy.",2016,10.1016/j.chest.2016.05.001,150,3,613-620,eng,1931-3543 0012-3692,"medical informatics and United States and Humans and Medical Informatics and United States Department of Veterans Affairs and Female and Male and Adult and electronic health records and primary care and health information technology and *Algorithms and lung cancer and Tomography, X-Ray Computed and Radiography, Thoracic and *Electronic Health Records and Delayed Diagnosis/*prevention & control and Lung Neoplasms/diagnosis/*diagnostic imaging and radiology and triggers",NA,NA,2016/09//undefined,Chest,NA,NA,NA,NA
Sinha_2020_TheLanResmed,JOUR,Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trials,"Sinha, Pratik and Delucchi, Kevin L. and McAuley, Daniel F. and O'Kane, Cecilia M. and Matthay, Michael A. and Calfee, Carolyn S.",The Lancet. Respiratory medicine,"BACKGROUND: Using latent class analysis (LCA) in five randomised controlled trial (RCT) cohorts, two distinct phenotypes of acute respiratory distress syndrome (ARDS) have been identified: hypoinflammatory and hyperinflammatory. The phenotypes are associated with differential outcomes and treatment response. The objective of this study was to develop parsimonious models for phenotype identification that could be accurate and feasible to use in the clinical setting. METHODS: In this retrospective study, three RCT cohorts from the National Lung, Heart, and Blood Institute ARDS Network (ARMA, ALVEOLI, and FACTT) were used as the derivation dataset (n=2022), from which the machine learning and logistic regression classifer models were derived, and a fourth (SAILS; n=715) from the same network was used as the validation test set. LCA-derived phenotypes in all of these cohorts served as the reference standard. Machine-learning algorithms (random forest, bootstrapped aggregating, and least absolute shrinkage and selection operator) were used to select a maximum of six important classifier variables, which were then used to develop nested logistic regression models. Only cases with complete biomarker data in the derivation dataset were used for variable selection. The best logistic regression models based on parsimony and predictive accuracy were then evaluated in the validation test set. Finally, the models' prognostic validity was tested in two external ARDS clinical trial datasets (START and HARP-2) by assessing mortality at days 28, 60, and 90 and ventilator-free days to day 28. FINDINGS: The six most important classifier variables were interleukin (IL)-8, IL-6, protein C, soluble tumour necrosis factor receptor 1, bicarbonate, and vasopressor use. From the nested models, three-variable (IL-8, bicarbonate, and protein C) and four-variable (3-variable plus vasopressor use) models were adjudicated to be the best performing. In the validation test set, both models showed good accuracy (AUC 0<c2><b7>94 [95% CI 0<c2><b7>92-0<c2><b7>95] for the three-variable model and 0<c2><b7>95 [95% CI 0<c2><b7>93-0<c2><b7>96] for the four-variable model) against LCA classifications. As with LCA-derived phenotypes, the hyperinflammatory phenotype as identified by the classifier model was associated with higher mortality at day 90 (87 [39%] of 223 patients vs 112 [23%] of 492 patients; p<0<c2><b7>0001) and fewer ventilator-free days (median 14 days [IQR 0-22] vs 22 days [0-25]; p<0<c2><b7>0001). In the external validation datasets, three-variable models developed in the derivation dataset identified two phenotypes with distinct clinical features and outcomes consistent with previous findings, including differential survival with simvastatin versus placebo in HARP-2 (p=0<c2><b7>023 for survival at 28 days). INTERPRETATION: ARDS phenotypes can be accurately identified with parsimonious classifier models using three or four variables. Pending the development of real-time testing for key biomarkers and prospective validation, these models could facilitate identification of ARDS phenotypes to enable their application in clinical trials and practice. FUNDING: National Institutes of Health.",2020,10.1016/S2213-2600(19)30369-8,8,3,247-257,eng,2213-2619 2213-2600,Humans and Female and Male and Adult and Middle Aged and Retrospective Studies and Aged and Machine Learning and Randomized Controlled Trials as Topic and Predictive Value of Tests and Phenotype and Biomarkers/blood and Inflammation Mediators/*blood and Respiratory Distress Syndrome/blood/*classification/therapy,NA,NA,2020/03//undefined,Lancet Respir Med,NA,NA,NA,NA
Pope_2020_Amjoofreancrcame,JOUR,Making Medical Treatment Decisions for Unrepresented Patients in the ICU. An Official American Thoracic Society/American Geriatrics Society Policy Statement,"Pope, Thaddeus M. and Bennett, Joshua and Carson, Shannon S. and Cederquist, Lynette and Cohen, Andrew B. and DeMartino, Erin S. and Godfrey, David M. and Goodman-Crews, Paula and Kapp, Marshall B. and Lo, Bernard and Magnus, David C. and Reinke, Lynn F. and Shirley, Jamie L. and Siegel, Mark D. and Stapleton, Renee D. and Sudore, Rebecca L. and Tarzian, Anita J. and Thornton, J. Daryl and Wicclair, Mark R. and Widera, Eric W. and White, Douglas B.",American journal of respiratory and critical care medicine,"Background and Rationale: ICU clinicians regularly care for patients who lack capacity, an applicable advance directive, and an available surrogate decision-maker. Although there is no consensus on terminology, we refer to these patients as ""unrepresented."" There is considerable controversy about how to make treatment decisions for these patients, and there is significant variability in both law and clinical practice.Purpose and Objectives: This multisociety statement provides clinicians and hospital administrators with recommendations for decision-making on behalf of unrepresented patients in the critical care setting.Methods: An interprofessional, multidisciplinary expert committee developed this policy statement by using an iterative consensus process with a diverse working group representing critical care medicine, palliative care, pediatric medicine, nursing, social work, gerontology, geriatrics, patient advocacy, bioethics, philosophy, elder law, and health law.Main Results: The committee designed its policy recommendations to promote five ethical goals: 1) to protect highly vulnerable patients, 2) to demonstrate respect for persons, 3) to provide appropriate medical care, 4) to safeguard against unacceptable discrimination, and 5) to avoid undue influence of competing obligations and conflicting interests. These recommendations also are intended to strike an appropriate balance between excessive and insufficient procedural safeguards. The committee makes the following recommendations: 1) institutions should offer advance care planning to prevent patients at high risk for becoming unrepresented from meeting this definition; 2) institutions should implement strategies to determine whether seemingly unrepresented patients are actually unrepresented, including careful capacity assessments and diligent searches for potential surrogates; 3) institutions should manage decision-making for unrepresented patients using input from a diverse interprofessional, multidisciplinary committee rather than ad hoc by treating clinicians; 4) institutions should use all available information on the patient's preferences and values to guide treatment decisions; 5) institutions should manage decision-making for unrepresented patients using a fair process that comports with procedural due process; 6) institutions should employ this fair process even when state law authorizes procedures with less oversight.Conclusions: This multisociety statement provides guidance for clinicians and hospital administrators on medical decision-making for unrepresented patients in the critical care setting.",2020,10.1164/rccm.202003-0512ST,201,10,1182-1192,eng,1535-4970 1073-449X,"Geriatrics and Humans and Patient Care Team and Judgment and Patient Advocacy and Societies, Medical and Patient Preference and Advance Care Planning and Clinical Decision-Making and *Intensive Care Units and Decision Making/*ethics and *Proxy and surrogate and Critical Care/ethics/*standards and adult orphan and patient without advocate and Pulmonary Medicine and substituted judgment and unrepresented",NA,NA,2020/05/15/,Am J Respir Crit Care Med,NA,NA,NA,NA
Doyle_2020_TheEurresjou,JOUR,Identification of potentially undiagnosed patients with nontuberculous mycobacterial lung disease using machine learning applied to primary care data in the UK,"Doyle, Orla M. and van der Laan, Roald and Obradovic, Marko and McMahon, Peter and Daniels, Flora and Pitcher, Ashley and Loebinger, Michael R.",The European respiratory journal,"Nontuberculous mycobacterial lung disease (NTMLD) is a rare lung disease often missed due to a low index of suspicion and unspecific clinical presentation. This retrospective study was designed to characterise the prediagnosis features of NTMLD patients in primary care and to assess the feasibility of using machine learning to identify undiagnosed NTMLD patients.IQVIA Medical Research Data (incorporating THIN, a Cegedim Database), a UK electronic medical records primary care database was used. NTMLD patients were identified between 2003 and 2017 by diagnosis in primary or secondary care or record of NTMLD treatment regimen. Risk factors and treatments were extracted in the prediagnosis period, guided by literature and expert clinical opinion. The control population was enriched to have at least one of these features.741 NTMLD and 112 784 control patients were selected. Annual prevalence rates of NTMLD from 2006 to 2016 increased from 2.7 to 5.1 per 100 000. The most common pre-existing diagnoses and treatments for NTMLD patients were COPD and asthma and penicillin, macrolides and inhaled corticosteroids. Compared to random testing, machine learning improved detection of patients with NTMLD by almost a thousand-fold with AUC of 0.94. The total prevalence of diagnosed and undiagnosed cases of NTMLD in 2016 was estimated to range between 9 and 16 per 100 000.This study supports the feasibility of machine learning applied to primary care data to screen for undiagnosed NTMLD patients, with results indicating that there may be a substantial number of undiagnosed cases of NTMLD in the UK.",2020,10.1183/13993003.00045-2020,56,4,2000045,eng,1399-3003 0903-1936,Humans and Primary Health Care and Retrospective Studies and Machine Learning and United Kingdom/epidemiology and *Lung Diseases/diagnosis/epidemiology,NA,NA,2020/10//undefined,Eur Respir J,NA,NA,NA,NA
Das_2020_TheEurresjou,JOUR,Deep-learning algorithm helps to standardise ATS/ERS spirometric acceptability and usability criteria,"Das, Nilakash and Verstraete, Kenneth and Stanojevic, Sanja and Topalovic, Marko and Aerts, Jean-Marie and Janssens, Wim",The European respiratory journal,"RATIONALE: While American Thoracic Society (ATS)/European Respiratory Society (ERS) quality control criteria for spirometry include several quantitative limits, it also requires manual visual inspection. The current approach is time consuming and leads to high intertechnician variability. We propose a deep-learning approach called convolutional neural network (CNN), to standardise spirometric manoeuvre acceptability and usability. METHODS AND METHODS: In 36 873 curves from the National Health and Nutritional Examination Survey USA 2011-2012, technicians labelled 54% of curves as meeting ATS/ERS 2005 acceptability criteria with satisfactory start and end of test, but identified 93% of curves with a usable forced expiratory volume in 1 s. We processed raw data into images of maximal expiratory flow-volume curve (MEFVC), calculated ATS/ERS quantifiable criteria and developed CNNs to determine manoeuvre acceptability and usability on 90% of the curves. The models were tested on the remaining 10% of curves. We calculated Shapley values to interpret the models. RESULTS: In the test set (n=3738), CNN showed an accuracy of 87% for acceptability and 92% for usability, with the latter demonstrating a high sensitivity (92%) and specificity (96%). They were significantly superior (p<0.0001) to ATS/ERS quantifiable rule-based models. Shapley interpretation revealed MEFVC<1 s (MEFVC pattern within first second of exhalation) and plateau in volume-time were most important in determining acceptability, while MEFVC<1 s entirely determined usability. CONCLUSION: The CNNs identified relevant attributes in spirometric curves to standardise ATS/ERS manoeuvre acceptability and usability recommendations, and further provides individual manoeuvre feedback. Our algorithm combines the visual experience of skilled technicians and ATS/ERS quantitative rules in automating the critical phase of spirometry quality control.",2020,10.1183/13993003.00603-2020,56,6,2000603,eng,1399-3003 0903-1936,United States and Humans and Algorithms and Forced Expiratory Volume and Vital Capacity and *Deep Learning and Exhalation and Spirometry,NA,NA,2020/12//undefined,Eur Respir J,NA,NA,NA,NA
Terry_2014_Ches,JOUR,Health privacy is difficult but not impossible in a post-HIPAA data-driven world,"Terry, Nicolas",Chest,"In the 13 years since their promulgation, the Health Insurance Portability and Accountability Act (HIPAA) rules and their enforcement have shown considerable evolution, as has the context within which they operate. Increasingly, it is the health information circulating outside the HIPAA-protected zone that is concerning: big data based on HIPAA data that have been acquired by public health agencies and then sold; medically inflected data collected from transactions or social media interactions; and the health data curated by patients, such as personal health records or data stored on smartphones. HIPAA does little here, suggesting that the future of health privacy may well be at the state level unless technology or federal legislation can catch up with state-of-the-art privacy regimes, such as the latest proposals from the European Commission.",2014,10.1378/chest.13-2909,146,3,835-840,eng,1931-3543 0012-3692,"Public Health and United States and Humans and Health Records, Personal and Social Media and *Health Insurance Portability and Accountability Act and Confidentiality/*trends",NA,NA,2014/09//undefined,Chest,NA,NA,NA,NA
Scheunemann_2012_Amjoofreancrcame,JOUR,The facilitated values history: helping surrogates make authentic decisions for incapacitated patients with advanced illness,"Scheunemann, Leslie P. and Arnold, Robert M. and White, Douglas B.",American journal of respiratory and critical care medicine,"Many patients who develop incapacitating illness have not expressed clear treatment preferences. Therefore, surrogate decision makers are asked to make judgments about what treatment pathway is most consistent with the patient's values. Surrogates often struggle with such decisions. The difficulty arises because answering the seemingly straightforward question, ""What do you think the patient would choose?"" is emotionally, cognitively, and morally complex. There is little guidance for clinicians to assist families in constructing an authentic picture of the patient's values and applying them to medical decisions, in part because current models of medical decision making treat the surrogate as the expert on the patient's values and the physician as the expert on technical medical considerations. However, many surrogates need assistance in identifying and working through the sometimes conflicting values relevant to medical decisions near the end of life. We present a framework for clinicians to help surrogates overcome the emotional, cognitive, and moral barriers to high-quality surrogate decision making for incapacitated patients.",2012,10.1164/rccm.201204-0710CP,186,6,480-486,eng,1535-4970 1073-449X,Humans and Female and Male and Guidelines as Topic and *Resuscitation Orders and *Professional-Family Relations and *Terminally Ill and Terminal Care/*ethics/methods and Third-Party Consent/ethics and Informed Consent/ethics/standards and Advance Care Planning/ethics/*standards and Life Support Care/ethics/standards,NA,NA,2012/09/15/,Am J Respir Crit Care Med,NA,NA,NA,NA
Chow_2010_Ches,JOUR,CURVES: a mnemonic for determining medical decision-making capacity and providing emergency treatment in the acute setting,"Chow, Grant V. and Czarny, Matthew J. and Hughes, Mark T. and Carrese, Joseph A.",Chest,"The evaluation of medical decision-making capacity and provision of emergency treatment in the acute care setting may present a significant challenge for both physicians-in-training and attending physicians. Although absolutely essential to the proper care of patients, recalling criteria for decision-making capacity may prove cumbersome during a medical emergency. Likewise, the requirements for providing emergency treatment must be fulfilled. This article presents a mnemonic (CURVES: Choose and Communicate, Understand, Reason, Value, Emergency, Surrogate) that addresses the abilities a patient must possess in order to have decision-making capacity, as well as the essentials of emergency treatment. It may be used in conjunction with, or in place of, lengthier capacity-assessment tools, particularly when time is of the essence. In addition, the proposed tool assists the practitioner in deciding whether emergency treatment may be administered, and in documenting medical decisions made during an acute event.",2010,10.1378/chest.09-1133,137,2,421-427,eng,1931-3543 0012-3692,"Humans and Female and Male and Middle Aged and Time Factors and Aged, 80 and over and Acute Disease and Clinical Competence and *Decision Making and *Emergencies and Positive-Pressure Respiration/*methods and Intubation, Intratracheal/*methods and Pulmonary Disease, Chronic Obstructive/*therapy and Sleep Apnea, Obstructive/*therapy",NA,NA,2010/02//undefined,Chest,NA,NA,NA,NA
Cerminara_2011_Ches,JOUR,The law and its interaction with medical ethics in end-of-life decision making,"Cerminara, Kathy L.",Chest,"The previous two articles in this series explored the historical and theoretical development of medical decision making from initial reliance on medical beneficence to a more recent emphasis on patient autonomy. The law of withholding and withdrawal of treatment has much in common with medical ethics. It is based on concerns about patient autonomy expressed by courts, legislatures, and the executive branch of the government. Legally, the patient's right of self-determination has been based on a variety of sources ranging from state and federal constitutions to the common law of torts and from cases to statutes and regulations. Understanding the various sources of the law, the distinctions among those sources, and the interaction of the branches of government in this context assists in understanding the law itself. In our federalist system of government, significant legal variations can exist among the states, but although technically valid, excessive concern about compliance with the precise contours of each state's statute when surrogate decision makers are engaging in bedside deliberations is unnecessary. Regardless of source or precise legal contours, the overall goal, which neither the physician nor the patient's surrogate or proxy decision makers should forget, is to honor what the patient would want to have done. Physicians and attorneys will agree on that as a matter of both ethics and the law.",2011,10.1378/chest.10-1612,140,3,775-780,eng,1931-3543 0012-3692,"United States and Humans and Personal Autonomy and *Ethics, Medical and Decision Making/*ethics and Beneficence and *Legislation, Medical and Mental Competency/legislation & jurisprudence and Treatment Refusal/ethics and Terminal Care/*ethics/*legislation & jurisprudence",NA,NA,2011/09//undefined,Chest,NA,NA,NA,NA
Simonds_2009_TheEurresjou,JOUR,Lives on the line? Ethics and practicalities of duty of care in pandemics and disasters,"Simonds, A. K. and Sokol, D. K.",The European respiratory journal,"Pandemics and acute emergencies raise pressing medical, ethical and organisational challenges. These include global governance, priority setting, triaging of patients, allocation of scarce resources and restricting individual liberty in the interests of public health. We will focus particularly on an issue of direct relevance to all respiratory team members, i.e. what is the duty of the healthcare worker to continue working in the face of personal risk, and draw lessons from guidelines, ethical considerations, past pandemics and evolving experience with H1N1 swine influenza.",2009,10.1183/09031936.00041609,34,2,303-309,eng,1399-3003 0903-1936,"Risk and Humans and Emergencies and *Ethics, Medical and Decision Making/ethics and *Disease Outbreaks and *Disasters and Refusal to Treat/ethics and Emergency Medical Services/ethics and Health Personnel/ethics and Influenza A Virus, H1N1 Subtype/metabolism and Influenza, Human/*therapy and Occupational Exposure and Pulmonary Medicine/*ethics and Severe Acute Respiratory Syndrome/therapy",NA,NA,2009/08//undefined,Eur Respir J,NA,NA,NA,NA
Nava_2007_TheEurresjou,JOUR,End-of-life decision-making in respiratory intermediate care units: a European survey,"Nava, S. and Sturani, C. and Hartl, S. and Magni, G. and Ciontu, M. and Corrado, A. and Simonds, A.",The European respiratory journal,"A survey was performed on behalf of the European Respiratory Society to assess end-of-life practices in patients admitted to European respiratory intermediate care units and high dependency units over a 6-month period. A 33-item questionnaire was sent by e-mail to physicians throughout Europe and the response rate was 28 (29.5%) out of 95. A total of 6,008 patients were admitted and an end-of-life decision was taken in 1,292 (21.5%). The mortality rate in these patients was 68% (884 out of 1,292). The patients received similar proportions of withholding of treatment (298 (23%) out of 1292), do-not-resuscitate or do-not-intubate orders (442 (34%) out of 1,292) and noninvasive mechanical ventilation as the ceiling of ventilatory care (402 (31%) out of 1,292). Withdrawal of therapy was employed in 149 (11%) out of 1,292 patients and euthanasia in one. Do-not-intubate/do-not-resuscitate orders were more frequently used in North compared with South Europe. All of the 473 competent patients directly participated in the decision, whereas, in 722 (56%) out of 1,292 cases, decision-making was reported to be shared with the nurses. In European respiratory intermediate care units and high dependency units, an end-of-life decision is taken for 21.5% of patients admitted. Withholding of treatment, do-not-intubate/do-not-resuscitate orders and noninvasive mechanical ventilation as the ventilatory care ceiling are the most common procedures. Competent patients are often involved, together with nurses.",2007,10.1183/09031936.00128306,30,1,156-164,eng,0903-1936,"Physicians and Humans and Female and Male and Adult and Middle Aged and Decision Making and Surveys and Questionnaires and Europe and Attitude of Health Personnel and Withholding Treatment and Ethics, Medical and Resuscitation Orders and Terminal Care/*methods/trends and Euthanasia, Passive and *Respiratory Care Units",NA,NA,2007/07//undefined,Eur Respir J,NA,NA,NA,NA
Lawrence_2009_Amjoofreancrcame,JOUR,Antimicrobial stewardship in the intensive care unit: advances and obstacles,"Lawrence, Kevin L. and Kollef, Marin H.",American journal of respiratory and critical care medicine,"Antimicrobial stewardship involves a multifaceted approach that strives to combat the emergence of resistance, improve clinical outcomes, and control costs by improving antimicrobial use. Therefore, stewardship is of great importance and relevance in the intensive care unit. Clinical decision support systems, biomarker-derived treatment algorithms, and improved knowledge regarding the different components of antimicrobial therapy represent some of the advances that have been made in stewardship. Yet, significant obstacles have prevented the full achievement of stewardship's goals, and approaches to confronting these obstacles should be appreciated. Clinicians should realize that antimicrobials are important therapeutic agents and strive to use them wisely.",2009,10.1164/rccm.200809-1394CP,179,6,434-438,eng,1535-4970 1073-449X,"Humans and Algorithms and Decision Support Systems, Clinical and Infection Control and Practice Patterns, Physicians' and DNA, Bacterial/isolation & purification and *Intensive Care Units and Biomarkers/blood and Anti-Bacterial Agents/*therapeutic use and Bacterial Infections/diagnosis/*drug therapy and C-Reactive Protein/analysis and Calcitonin/blood and Drug Resistance, Bacterial and Protein Precursors/blood",NA,NA,2009/03/15/,Am J Respir Crit Care Med,NA,NA,NA,NA
Infante_2013_TheEurresjou,JOUR,Slow-growing lung cancer as an emerging entity: from screening to clinical management,"Infante, Maurizio and Berghmans, Thierry and Heuvelmans, Marjolein A. and Hillerdal, Gunnar and Oudkerk, Matthijs",The European respiratory journal,"The current paradigm is that untreated lung cancer is invariably and rapidly fatal, therefore the medical community normally dismisses the idea that a patient could live with such a disease for years without any therapy. Yet evidence from lung cancer screening research and from recent clinical series suggests that, although rarely recognised in routine practice, slow-growing lung cancers do exist and are more common than previously thought. Here, current evidence is reviewed and clinical cases are illustrated to show that slow-growing lung cancer is a real clinical entity, and the reasons why management protocols developed in the screening setting may also be useful in clinical practice are discussed. Features suggesting that a lung cancer may be slow-growing are described and appraised, areas of uncertainty are examined, modern management options for early-stage disease are evaluated and the influence that all this knowledge might have on our clinical decision-making is weighed. Further research directed at developing appropriate guidelines for these peculiar but increasingly common patients is warranted.",2013,10.1183/09031936.00186212,42,6,1706-1722,eng,1399-3003 0903-1936,"Risk and Humans and Time Factors and Decision Making and Treatment Outcome and Prognosis and Disease Progression and Early Detection of Cancer and Tomography, X-Ray Computed and Imaging, Three-Dimensional and Lung Neoplasms/*diagnosis/*therapy and Multiple Pulmonary Nodules and Smoking/adverse effects",NA,NA,2013/12//undefined,Eur Respir J,NA,NA,NA,NA
Toffart_2015_TheEurresjou,JOUR,Selection criteria for intensive care unit referral of lung cancer patients: a pilot study,"Toffart, Anne-Claire and Pizarro, Carola Alegria and Schwebel, Carole and Sakhri, Linda and Minet, Clemence and Duruisseaux, Michael and Azoulay, Elie and Moro-Sibilot, Denis and Timsit, Jean-Francois",The European respiratory journal,"The decision-making process for the intensity of care delivered to patients with lung cancer and organ failure is poorly understood, and does not always involve intensivists. Our objective was to describe the potential suitability for intensive care unit (ICU) referral of lung cancer in-patients with organ failures. We prospectively included consecutive lung cancer patients with failure of at least one organ admitted to the teaching hospital in Grenoble, France, between December 2010 and October 2012. Of 140 patients, 121 (86%) were evaluated by an oncologist and 49 (35%) were referred for ICU admission, with subsequent admission for 36 (73%) out of those 49. Factors independently associated with ICU referral were performance status <e2><a9><bd>2 (OR 10.07, 95% CI 3.85-26.32), nonprogressive malignancy (OR 7.00, 95% CI 2.24-21.80), and no explicit refusal of ICU admission by the patient and/or family (OR 7.95, 95% CI 2.39-26.37). Factors independently associated with ICU admission were the initial ward being other than the lung cancer unit (OR 6.02, 95% CI 1.11-32.80) and an available medical ICU bed (OR 8.19, 95% CI 1.48-45.35). Only one-third of lung cancer patients with organ failures were referred for ICU admission. The decision not to consider ICU admission was often taken by a non-intensivist, with advice from an oncologist rather than an intensivist.",2015,10.1183/09031936.00118114,45,2,491-500,eng,1399-3003 0903-1936,Humans and Female and Male and Middle Aged and Aged and Time Factors and Decision Making and Pilot Projects and Prospective Studies and Prognosis and Disease Progression and Patient Admission and Intensive Care Units and France and *Patient Selection and *Referral and Consultation and Critical Care/*organization & administration and Lung Neoplasms/*therapy and Medical Oncology/organization & administration,NA,NA,2015/02//undefined,Eur Respir J,NA,NA,NA,NA
Cooke_2013_Amjoofreancrcame,JOUR,Advancing clinical practice and policy through guidelines: the role of the American Thoracic Society,"Cooke, Colin R. and Gould, Michael K.",American journal of respiratory and critical care medicine,"In the face of an overwhelmingly large and growing medical literature, providers often turn to clinical practice guidelines to inform the decisions they make with patients. By systematically appraising the evidence and providing transparent recommendations for practice, guidelines have the potential to improve both bedside decision-making and health policy. This potential has not been fully realized because most guidelines lack transparency, are tainted by conflicts of interest, or fail to employ rigorous methods to appraise the evidence. To address the shortcomings of past guidelines, the Institute of Medicine (IOM) published recommendations for trustworthy guidelines, effectively setting the ""gold standard"" for what constitutes a high-quality guideline. Along with many other groups that develop guidelines, the American Thoracic Society (ATS) is rapidly evolving processes for development and implementation to meet many of the IOM standards. This Pulmonary Perspective describes the rapidly changing landscape of clinical practice guidelines, the role of the ATS in this landscape, and the activities the ATS is engaged in to ensure that the guidelines it produces are of the highest quality with the broadest impact.",2013,10.1164/rccm.201301-0009PP,187,9,910-914,eng,1535-4970 1073-449X,"United States and Humans and Decision Making and Societies, Medical and Practice Guidelines as Topic/*standards and Evidence-Based Medicine/*standards and National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division and Pulmonary Medicine/methods/*standards",NA,NA,2013/05/01/,Am J Respir Crit Care Med,NA,NA,NA,NA
White_2009_Amjoofreancrcame,JOUR,Are physicians' recommendations to limit life support beneficial or burdensome? Bringing empirical data to the debate,"White, Douglas B. and Evans, Leah R. and Bautista, Christopher A. and Luce, John M. and Lo, Bernard",American journal of respiratory and critical care medicine,"RATIONALE: Although there is a growing belief that physicians should routinely provide a recommendation to surrogates during deliberations about withdrawing life support, there is a paucity of empirical data on surrogates' perspectives on this topic. OBJECTIVES: To understand the attitudes of surrogate decision-makers toward receiving a physician's recommendation during deliberations about whether to limit life support for an incapacitated patient. METHODS: We conducted a prospective, mixed methods study among 169 surrogate decision-makers for critically ill patients. Surrogates sequentially viewed two videos of simulated physician-surrogate discussions about whether to limit life support, which varied only by whether the physician gave a recommendation. MEASUREMENTS AND MAIN RESULTS: The main quantitative outcome was whether surrogates preferred to receive a physicians' recommendation. Surrogates also participated in an in-depth, semistructured interview to explore the reasons for their preference. Fifty-six percent (95/169) of surrogates preferred to receive a recommendation, 42% (70/169) preferred not to receive a recommendation, and 2% (4/169) felt that both approaches were equally acceptable. We identified four main themes that explained surrogates' preferences, including surrogates' perceptions of physicians' appropriate role in life or death decisions and their perceptions of the positive or negative consequences of a recommendation on the physician-surrogate relationship, on the decision-making process, and on long-term regret for the family. CONCLUSIONS: There is no consensus among surrogates about whether physicians should routinely provide a recommendation regarding life support decisions for incapacitated patients. These findings suggest that physicians should ask surrogates whether they wish to receive a recommendation regarding life support decisions and should be flexible in their approach to decision-making.",2009,10.1164/rccm.200811-1776OC,180,4,320-325,eng,1535-4970 1073-449X,"Humans and Female and Male and Adult and Middle Aged and Aged and Prospective Studies and Practice Guidelines as Topic and Ethics, Medical and Decision Making/ethics and Empathy and *Attitude and Physician's Role/*psychology and *Professional-Family Relations/ethics and Euthanasia, Passive/ethics/*psychology and Intensive Care Units/ethics and Legal Guardians/education/*psychology and Life Support Care/ethics/*psychology",NA,NA,2009/08/15/,Am J Respir Crit Care Med,NA,NA,NA,NA
Navani_2015_TheLanResmed,JOUR,"Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic, randomised controlled trial","Navani, Neal and Nankivell, Matthew and Lawrence, David R. and Lock, Sara and Makker, Himender and Baldwin, David R. and Stephens, Richard J. and Parmar, Mahesh K. and Spiro, Stephen G. and Morris, Stephen and Janes, Sam M.",The Lancet. Respiratory medicine,"BACKGROUND: The diagnosis and staging of lung cancer is an important process that identifies treatment options and guides disease prognosis. We aimed to assess endobronchial ultrasound-guided transbronchial needle aspiration as an initial investigation technique for patients with suspected lung cancer. METHODS: In this open-label, multicentre, pragmatic, randomised controlled trial, we recruited patients who had undergone a CT scan and had suspected stage I to IIIA lung cancer, from six UK centres and randomly assigned them to either endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) or conventional diagnosis and staging (CDS), for further investigation and staging. If a target node could not be accessed by EBUS-TBNA, then endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) was allowed as an alternative procedure. Randomisation was stratified according to the presence of mediastinal lymph nodes measuring 1 cm or more in the short axis and by recruiting centre. We used a telephone randomisation method with permuted blocks of four generated by a computer. Because of the nature of the intervention, masking of participants and consenting investigators was not possible. The primary endpoint was the time-to-treatment decision after completion of the diagnostic and staging investigations and analysis was by intention-to-diagnose. This trial is registered with ClinicalTrials.gov, number NCT00652769. FINDINGS: Between June 10, 2008, and July 4, 2011, we randomly allocated 133 patients to treatment: 66 to EBUS-TBNA and 67 to CDS (one later withdrew consent). Two patients from the EBUS-TBNA group underwent EUS-FNA. The median time to treatment decision was shorter with EBUS-TBNA (14 days; 95% CI 14-15) than with CDS (29 days; 23-35) resulting in a hazard ratio of 1<c2><b7>98, (1<c2><b7>39-2<c2><b7>82, p<0<c2><b7>0001). One patient in each group had a pneumothorax from a CT-guided biopsy sample; the patient from the CDS group needed intercostal drainage and was admitted to hospital. INTERPRETATION: Transbronchial needle aspiration guided by endobronchial ultrasound should be considered as the initial investigation for patients with suspected lung cancer, because it reduces the time to treatment decision compared with conventional diagnosis and staging techniques. FUNDING: UK Medical Research Council.",2015,10.1016/S2213-2600(15)00029-6,3,4,282-289,eng,2213-2619 2213-2600,"Humans and Female and Male and Middle Aged and Aged and Time Factors and Proportional Hazards Models and Tomography, X-Ray Computed and Neoplasm Staging and Clinical Decision-Making and Lymph Nodes/*pathology and Positron-Emission Tomography and Biopsy/methods and Bronchoscopy/*methods and Carcinoma, Non-Small-Cell Lung/diagnosis/*pathology and Endoscopic Ultrasound-Guided Fine Needle Aspiration/*methods and Lung Neoplasms/diagnosis/*pathology and Lung/diagnostic imaging/*pathology and Mediastinoscopy and Multimodal Imaging",NA,NA,2015/04//undefined,Lancet Respir Med,NA,NA,NA,NA
Tonelli_2012_Amjoofreancrcame,JOUR,An official multi-society statement: the role of clinical research results in the practice of critical care medicine,"Tonelli, Mark R. and Curtis, J. Randall and Guntupalli, Kalpalatha K. and Rubenfeld, Gordon D. and Arroliga, Alejandro C. and Brochard, Laurent and Douglas, Ivor S. and Gutterman, David D. and Hall, Jesse R. and Kavanagh, Brian P. and Mancebo, Jordi and Misak, Cheryl J. and Simpson, Steven Q. and Slutsky, Arthur S. and Suffredini, Anthony F. and Thompson, B. Taylor and Ware, Lorraine B. and Wheeler, Arthur P. and Levy, Mitchell M.",American journal of respiratory and critical care medicine,"BACKGROUND: While the results of clinical research are clearly valuable in the care of critically ill patients, the limitations of such information and the role of other forms of medical knowledge for clinical decision making have not been carefully examined. METHODS: The leadership of three large professional societies representing critical care practitioners convened a diverse group representing a wide variety of views regarding the role of clinical research results in clinical practice to develop a document to serve as a basis for agreement and a framework for ongoing discussion. RESULTS: Consensus was reached on several issues. While the results of rigorous clinical research are important in arriving at the best course of action for an individual critically ill patient, other forms of medical knowledge, including clinical experience and pathophysiologic reasoning, remain essential. No single source of knowledge is sufficient to guide clinical decisions, nor does one kind of knowledge always take precedence over others. Clinicians will find clinical research compelling for a variety of reasons that go beyond study design. While clinical practice guidelines and protocols based upon clinical research may improve care and decrease variability in practice, clinicians must be able to understand and articulate the rationale as to why a particular protocol or guideline is used or why an alternative approach is taken. Making this clinical reasoning explicit is necessary to understand practice variability. CONCLUSIONS: Understanding the strengths and weaknesses of different kinds of medical knowledge for clinical decision making and factors beyond study design that make clinical research compelling to clinicians can provide a framework for understanding the role of clinical research in practice.",2012,10.1164/rccm.201204-0638ST,185,10,1117-1124,eng,1535-4970 1073-449X,"Humans and Evidence-Based Medicine and Knowledge Bases and Decision Support Techniques and Research Design and Clinical Protocols and Precision Medicine and Practice Patterns, Physicians' and *Biomedical Research and Critical Care/*methods",NA,NA,2012/05/15/,Am J Respir Crit Care Med,NA,NA,NA,NA
Damuth_2015_TheLanResmed,JOUR,Long-term survival of critically ill patients treated with prolonged mechanical ventilation: a systematic review and meta-analysis,"Damuth, Emily and Mitchell, Jessica A. and Bartock, Jason L. and Roberts, Brian W. and Trzeciak, Stephen",The Lancet. Respiratory medicine,"BACKGROUND: Prolonged dependence on mechanical ventilation after critical illness is an emerging public health challenge; however, long-term outcomes are incompletely understood. We aimed to systematically analyse long-term survival of critically ill patients treated with prolonged mechanical ventilation. METHODS: We searched PubMed, CINAHL, and the Cochrane Library between 1988 and Nov 6, 2013, with no language restrictions, for studies on prolonged mechanical ventilation. We included studies of adult populations treated with mechanical ventilation for more than 14 days, who were admitted to a ventilator weaning unit, or who had a tracheostomy for acute respiratory failure. We abstracted data with a standardised collection template and assessed study quality (ie, risk of bias) using a customised Newcastle-Ottawa Scale. We did a stratified analysis based on study setting (eg, acute vs post-acute care hospitals), and used a random-effects model to calculate pooled statistics (proportions with 95% CIs) for all outcomes. We did sensitivity analyses based on study quality (ie, high-quality studies only) and country of origin (USA vs non-USA and USA vs UK). The primary outcome was mortality at 1 year. Secondary outcomes were in-hospital mortality, discharge destination among survivors, successful liberation from mechanical ventilation while in hospital, and mortality at timepoints longer than 1 year. FINDINGS: Of 6326 studies identified, 402 underwent full manuscript review, and 124 studies from 16 countries met the inclusion criteria. 39 studies reported mortality at 1 year, which was 59% (95% CI 56-62). Among the 29 high-quality studies, the pooled mortality at 1 year was 62% (95% CI 57-67). Pooled mortality at hospital discharge was 29% (95% CI 26-32). However, only 19% (16-24) were discharged to home and only 50% (47-53) were successfully liberated from mechanical ventilation. For studies in post-acute care hospitals, outcomes were worse in the USA than internationally (mortality at 1 year was 73% [95% CI 67-78] in the USA vs 47% [29-65] in non-USA countries; in-hospital mortality was 31% [26-37] vs 18% [14-24]; and liberation from ventilation was 47% [42-51] vs 63% [59-68]; p<0<c2><b7>0001 for all). INTERPRETATION: Although a high proportion of patients survived to hospital discharge, fewer than half of patients survived beyond 1 year. Future studies should focus on optimum patient selection for prolonged mechanical ventilation and integration of long-term outcome information into clinical decision making. FUNDING: Cooper University Health Care and Cooper Medical School of Rowan University.",2015,10.1016/S2213-2600(15)00150-2,3,7,544-553,eng,2213-2619 2213-2600,"Humans and Female and Male and Middle Aged and Aged and Treatment Outcome and Acute Disease and Hospitalization/statistics & numerical data and Critical Illness/mortality/*therapy and Long-Term Care/statistics & numerical data and Respiration, Artificial/*mortality and Respiratory Insufficiency/mortality/*therapy and Ventilator Weaning",NA,NA,2015/07//undefined,Lancet Respir Med,NA,NA,NA,NA
Will_2011_Ches,JOUR,A brief historical and theoretical perspective on patient autonomy and medical decision making: Part I: The beneficence model,"Will, Jonathan F.",Chest,"As part of a larger series addressing the intersection of law and medicine, this essay is the first of two introductory pieces. This article explores the nature of the physician-patient relationship and of the practice of medicine dating from the Hippocratic tradition to the end of the 19th century, a period during which a beneficence-based medical ethic remained relatively stable. The medical literature dating from the Hippocratic texts to the early codes of the American Medical Association did not include a meaningful role for the patient in the decision-making process. In fact, the practice of benevolent deception--the deliberate withholding of any information thought by the physician to be detrimental to the patient's prognosis--was encouraged. However, as philosophers identified an inherent value in respecting patient self-determination and the law imposed a duty on physicians to obtain informed consent, 2,400 years of relative stability under the beneficence model gave way to the autonomy model.",2011,10.1378/chest.10-2532,139,3,669-673,eng,1931-3543 0012-3692,"United States and Humans and History, Ancient and *Decision Support Techniques and History, 19th Century and Decision Making/*ethics and Physician-Patient Relations/ethics and Physicians/ethics/legislation & jurisprudence and History, 18th Century and History, Medieval and American Medical Association/history and Ethics, Medical/*history and Hippocratic Oath and History, 15th Century and History, 16th Century and History, 17th Century and Patient Participation/history and Patient Rights/ethics/*history/legislation & jurisprudence and Quality of Health Care/ethics/legislation & jurisprudence/standards",NA,NA,2011/03//undefined,Chest,NA,NA,NA,NA
Goeschel_2010_Ches,JOUR,Responsibility for quality improvement and patient safety: hospital board and medical staff leadership challenges,"Goeschel, Christine A. and Wachter, Robert M. and Pronovost, Peter J.",Chest,"Concern about the quality and safety of health care persists, 10 years after the 1999 Institute of Medicine report To Err is Human. Despite growing awareness of quality and safety risks, and significant efforts to improve, progress is difficult to measure. Hospital leaders, including boards and medical staffs, are accountable to improve care, yet they often address this duty independently. Shared responsibility for quality and patient safety improvement presents unique challenges and unprecedented opportunities for boards and medical staffs. To capitalize on the pressure to improve, both groups may benefit from a better understanding of their synergistic potential. Boards should be educated about the quality of care provided in their institutions and about the challenges of valid measurement and accurate reporting. Boards strengthen their quality oversight capacity by recruiting physicians for vacant board seats. Medical staff members strengthen their role as hospital leaders when they understand the unique duties of the governing board. A quality improvement strategy rooted in synergistic efforts by the board and the medical staff may offer the greatest potential for safer care. Such a mutually advantageous approach requires a clear appreciation of roles and responsibilities and respect for differences. In this article, we review these responsibilities, describe opportunities for boards and medical staffs to collaborate as leaders, and offer recommendations for how boards and medical staff members can address the challenges of shared responsibility for quality of care.",2010,10.1378/chest.09-2051,138,1,171-178,eng,1931-3543 0012-3692,"Humans and Risk Assessment/*methods and *Leadership and *Decision Making, Organizational and Governing Board/*standards and Medical Staff, Hospital/*organization & administration/*standards and Quality Assurance, Health Care/*trends",NA,NA,2010/07//undefined,Chest,NA,NA,NA,NA
Luce_2010_Amjoofreancrcame,JOUR,End-of-life decision making in the intensive care unit,"Luce, John M.",American journal of respiratory and critical care medicine,"Increasingly in the United States and other countries, medical decisions, including those at the end of life, are made using a shared decision-making model. Under this model, physicians and other clinicians help patients clarify their values and reach consensus about treatment courses consistent with them. Because most critically ill patients are decisionally impaired, family members and other surrogates must make end-of-life decisions for them, ideally in accord with a substituted judgment standard. Physicians generally make decisions for patients who lack families or other surrogates and have no advance directives, based on a best interests standard and occasionally in consultation with other physicians or with review by a hospital ethics committee. End-of-life decisions for patients with surrogates usually are made at family conferences, the functioning of which can be improved by several methods that have been demonstrated to improve communications. Facilitative ethics consultations can be helpful in resolving conflicts when physicians and families disagree in end-of-life decisions. Ethics committees actually are allowed to make such decisions in one state when disagreements cannot be resolved otherwise.",2010,10.1164/rccm.201001-0071CI,182,1,11-6,eng,1535-4970 1073-449X,"Humans and Physician-Patient Relations and Advance Directives and Palliative Care and Withholding Treatment and *Intensive Care Units and *Terminal Care and *Third-Party Consent and Ethics Committees, Clinical/legislation & jurisprudence",NA,NA,2010/07/01/,Am J Respir Crit Care Med,NA,NA,NA,NA
Gries_2008_Ches,JOUR,Family member satisfaction with end-of-life decision making in the ICU,"Gries, Cynthia J. and Curtis, J. Randall and Wall, Richard J. and Engelberg, Ruth A.",Chest,"RATIONALE: Families of ICU patients may be at risk for increased psychological morbidity due to end-of-life decision making. The identification of chart-based quality indicators of palliative care that predict family satisfaction with decision making may help to guide interventions to improve decision making and family outcomes. OBJECTIVE: To determine patient and family characteristics and chart the documentation of processes of care that are associated with increased family satisfaction with end-of-life decision making for ICU patients. METHODS: We conducted a cohort study of ICU patients dying in 10 medical centers in the Seattle-Tacoma area. MEASUREMENT: Outcomes from family surveys included summary scores for family satisfaction with decision making and a single-item score that indicated feeling supported during decision making. Predictor variables were obtained from surveys and chart abstraction. MAIN RESULTS: The survey response rate was 41% (442 of 1,074 families responded). Analyses were conducted of 356 families with questionnaire and chart abstraction data. Family satisfaction with decision making was associated with the withdrawal of life support, and chart documentation of physician recommendations to withdraw life support, discussions of patients' wishes, and discussions of families' spiritual needs. Feeling supported during decision making was associated with the withdrawal of life support, spiritual care involvement, and chart documentation of physician recommendations to withdraw life support, expressions of families' wishes to withdraw life support, and discussions of families' spiritual needs. CONCLUSIONS: Increased family satisfaction with decision making is associated with withdrawing life support and the documentation of palliative care indicators including the following: physician recommendations to withdraw life support; expressions of patients' wishes; and discussions of families' spiritual needs. These findings provide direction for future studies to investigate approaches to improving family satisfaction in end-of-life decision making. In addition, because there were few nonwhites in this study, these results may not be generalizable to more diverse populations. Future studies should target diverse populations in order to test whether similar factors are similarly important for end-of-life decision making.",2008,10.1378/chest.07-1773,133,3,704-712,eng,0012-3692 1931-3543,Humans and Female and Male and Middle Aged and Retrospective Studies and Surveys and Questionnaires and Washington and Follow-Up Studies and Withholding Treatment and *Decision Making and *Intensive Care Units and Family/*psychology and *Professional-Family Relations and Palliative Care/*methods and Terminal Care/methods/*psychology and Life Support Care/methods/*psychology,NA,NA,2008/03//undefined,Chest,NA,NA,NA,NA
Goligher_2015_Amjoofreancrcame,JOUR,"Update in Mechanical Ventilation, Sedation, and Outcomes 2014","Goligher, Ewan C. and Doufle, Ghislaine and Fan, Eddy",American journal of respiratory and critical care medicine,"Novel approaches to the management of acute respiratory distress syndrome include strategies to enhance alveolar liquid clearance, promote epithelial cell growth and recovery after acute lung injury, and individualize ventilator care on the basis of physiological responses. The use of extracorporeal membrane oxygenation (ECMO) is growing rapidly, and centers providing ECMO must strive to meet stringent quality standards such as those set out by the ECMONet working group. Prognostic tools such as the RESP score can assist clinicians in predicting outcomes for patients with severe acute respiratory failure but do not predict whether ECMO will enhance survival. Evidence continues to grow that novel modes of mechanical ventilation such as neurally adjusted ventilatory assist are feasible and improve patient physiology and patient-ventilator interaction; data on clinical outcomes are limited but supportive. Critical illness causes long-term psychological and function sequelae: the risk of a new psychiatric diagnosis and severe physical impairment is significantly increased in the months after discharge from the intensive care unit. These long-term effects might be amenable to changes in sedation practice and increased early mobilization. Daily sedation discontinuation enhances the validity of routine delirium assessment. Many critically ill patients merit assessment by palliative care clinicians; the demand for palliative care services among critically ill patients is expected to grow. Future trials to test therapies for critical illness must ensure that study designs are adequately powered to detect benefit using realistic event rates. Integrating ""big data"" approaches into treatment decisions and trial designs offers a potential means of individualizing care to enhance outcomes for critically ill patients.",2015,10.1164/rccm.201502-0346UP,191,12,1367-1373,eng,1535-4970 1073-449X,"Humans and outcomes and sepsis and Outcome Assessment, Health Care and Critical Illness and Intensive Care Units and resuscitation and mechanical ventilation and Anesthesia/*methods and Deep Sedation/methods and Extracorporeal Membrane Oxygenation/*methods and Respiration, Artificial/*methods and Respiratory Distress Syndrome/*therapy and sedation",NA,NA,2015/06/15/,Am J Respir Crit Care Med,NA,NA,NA,NA
Rivera_2018_Amjoofreancrcame,JOUR,Incorporating Coexisting Chronic Illness into Decisions about Patient Selection for Lung Cancer Screening. An Official American Thoracic Society Research Statement,"Rivera, M. Patricia and Tanner, Nichole T. and Silvestri, Gerard A. and Detterbeck, Frank C. and Tammemagi, Martin C. and Young, Robert P. and Slatore, Christopher G. and Caverly, Tanner J. and Boyd, Cynthia M. and Braithwaite, Dejana and Fathi, Joelle T. and Gould, Michael K. and Iaccarino, Jonathan M. and Malkoski, Stephen P. and Mazzone, Peter J. and Tanoue, Lynn T. and Schoenborn, Nancy L. and Zulueta, Javier J. and Wiener, Renda Soylemez",American journal of respiratory and critical care medicine,"BACKGROUND: Lung cancer screening (LCS) has the potential to reduce the risk of lung cancer death in healthy individuals, but the impact of coexisting chronic illnesses on LCS outcomes has not been well defined. Consideration of the complex relationship between baseline risk of lung cancer, treatment-related harms, and risk of death from competing causes is crucial in determining the balance of benefits and harms of LCS. OBJECTIVES: To summarize evidence, identify knowledge and research gaps, prioritize topics, and propose methods for future research on how best to incorporate comorbidities in making decisions regarding LCS. METHODS: A multidisciplinary group of international clinicians and researchers reviewed available data on the effects of comorbidities on LCS outcomes, focusing on the juxtaposition of lung cancer risk and competing risks of death, consideration of benefits and risks in patients with chronic obstructive pulmonary disease, communication of risk, and treatment of screen-detected lung cancer. RESULTS: This statement identifies gaps in knowledge regarding how comorbidities and competing causes of death impact outcomes in LCS, and we have developed questions to help guide future research efforts to better inform patient selection, education, and implementation of LCS. CONCLUSIONS: There is an urgent need for further research that can help guide clinical decision-making with patients who may not benefit from LCS owing to coexisting chronic illness. This statement establishes a research framework to address essential questions regarding how to incorporate and communicate risks of comorbidities into patient selection and decisions regarding LCS.",2018,10.1164/rccm.201805-0986ST,198,2,e13-e3,eng,1535-4970 1073-449X,"Humans and Female and Male and Adult and Middle Aged and Aged and Decision Making and Aged, 80 and over and Societies, Medical and *Patient Selection and *Practice Guidelines as Topic and *Comorbidity and *Chronic Disease and lung cancer screening and comorbidities and communication of risk and Early Detection of Cancer/*standards and Lung Neoplasms/*diagnosis and Mass Screening/*standards",NA,NA,2018/07/15/,Am J Respir Crit Care Med,NA,NA,NA,NA
Koth_2011_Amjoofreancrcame,JOUR,Sarcoidosis blood transcriptome reflects lung inflammation and overlaps with tuberculosis,"Koth, Laura L. and Solberg, Owen D. and Peng, Jeffrey C. and Bhakta, Nirav R. and Nguyen, Christine P. and Woodruff, Prescott G.",American journal of respiratory and critical care medicine,"RATIONALE: Sarcoidosis is a granulomatous disease of unknown etiology, although M. tuberculosis may play a role in the pathogenesis. The traditional view holds that inflammation in sarcoidosis is compartmentalized to involved organs. OBJECTIVES: To determine whether whole blood gene expression signatures reflect inflammatory pathways in the lung in sarcoidosis and whether these signatures overlap with tuberculosis. METHODS: We analyzed transcriptomic data from blood and lung biopsies in sarcoidosis and compared these profiles with blood transcriptomic data from tuberculosis and other diseases. MEASUREMENTS AND MAIN RESULTS: Applying machine learning algorithms to blood gene expression data, we built a classifier that distinguished sarcoidosis from health in derivation and validation cohorts (92% sensitivity, 92% specificity). The most discriminative genes were confirmed by quantitative PCR and correlated with disease severity. Transcript profiles significantly induced in blood overlapped with those in lung biopsies and identified shared dominant inflammatory pathways (e.g., Type-I/II interferons). Sarcoidosis and tuberculosis shared more overlap in blood gene expression compared with other diseases using the 86-gene signature reported to be specific for tuberculosis and the sarcoidosis signature presented herein, although reapplication of machine learning algorithms could identify genes specific for sarcoidosis. CONCLUSIONS: These data indicate that blood transcriptome analysis provides a noninvasive method for identifying inflammatory pathways in sarcoidosis, that these pathways may be leveraged to complement more invasive procedures for diagnosis or assessment of disease severity, and that sarcoidosis and tuberculosis share overlap in gene regulation of specific inflammatory pathways.",2011,10.1164/rccm.201106-1143OC,184,10,1153-1163,eng,1535-4970 1073-449X,"Humans and Female and Male and Middle Aged and Algorithms and Case-Control Studies and ROC Curve and Severity of Illness Index and Gene Expression Profiling and Real-Time Polymerase Chain Reaction and Transcriptome/*genetics and Biopsy, Needle and Inflammation/genetics/*metabolism and Lung/immunology/*metabolism/pathology and Sarcoidosis, Pulmonary/blood/genetics/*metabolism/pathology and Tuberculosis, Pulmonary/blood/genetics/*metabolism",NA,NA,2011/11/15/,Am J Respir Crit Care Med,NA,NA,NA,NA
Hinkle_2015_Ches,JOUR,Factors associated with family satisfaction with end-of-life care in the ICU: a systematic review,"Hinkle, Laura J. and Bosslet, Gabriel T. and Torke, Alexia M.",Chest,"BACKGROUND: Family satisfaction with end-of-life care in the ICU has not previously been systematically reviewed. Our objective was to perform a review, synthesizing published data identifying factors associated with family satisfaction with end-of-life care in critically ill adult populations. METHODS: The following electronic databases were searched: MEDLINE (Medical Literature Analysis and Retrieval System Online), MEDLINE Updated, EMBASE (Excerpta Medical Database), CINAHL (Cumulative Index to Nursing and Allied Health Literature), PsycInfo, and PubMed. Two authors reviewed retrieved titles and abstracts. Studies describing nonadult and non-ICU populations or not addressing end-of-life care, family satisfaction, or factors affecting satisfaction were excluded. The remaining articles underwent full review and data extraction by two authors. Quality was assessed using a checklist based on the recommendations of the Consolidated Standards for Reporting Trials group. RESULTS: The search yielded 1,072 articles, with 23 articles describing 14 studies meeting inclusion criteria. All studies obtained satisfaction data from family members via surveys and structured interviews. Specific communication strategies increasing satisfaction included: expressions of empathy, nonabandonment, and assurances of comfort and provision of written information. Additionally, support for shared decision-making, family presence at time of death, and specific patient-care measures such as extubation before death were associated with increased satisfaction. CONCLUSIONS: Good-quality communication, support for shared decision-making, and specific patient-care measures were associated with increased satisfaction with end-of-life care. Assessing the family's desire to participate in shared decision-making may also be an important factor. Few interventions increased satisfaction. Future research is needed to further define optimal communication strategies, understand effective integration of palliative care into the ICU, and define significant score changes in survey instruments.",2015,10.1378/chest.14-1098,147,1,82-93,eng,1931-3543 0012-3692,Humans and *Decision Making and *Personal Satisfaction and *Patient Participation and *Intensive Care Units and Family/*psychology and Terminal Care/*methods,NA,NA,2015/01//undefined,Chest,NA,NA,NA,NA
Pope_2012_Ches,JOUR,Legal fundamentals of surrogate decision making,"Pope, Thaddeus Mason",Chest,"The four previous articles in this series have traced the history of patient autonomy and have identified its ethical and legal foundations. Patient autonomy is highly valued in the United States to the extent that the patient does not lose the right of self-determination when he or she loses the capacity to make health-care decisions for him or herself. The law has devised several tools to promote ""prospective autonomy."" One mechanism is the instructional advance directive or living will. But most of us do not write such directives. Another mechanism is the proxy directive or durable power of attorney for health care, designating another person, a surrogate, to direct the course of our medical treatment upon our incapacity. But most of us do not do that either. Therefore, the most common mechanism by which our prospective autonomy is protected and promoted is through the informal selection of surrogates based on statutory priority lists. These ""default"" surrogates are the most numerous type of surrogate. This article explains the importance and legal fundamentals of surrogate decision making. It first describes five basic types of surrogates. The article then looks at the role of these surrogates and how they are supposed to make decisions on the patient's behalf. Unfortunately, surrogate performance is often mediocre or poor. There are significant and persistent obstacles to good surrogate decision making. After explaining these problems, the article concludes by identifying several solutions.",2012,10.1378/chest.11-2336,141,4,1074-1081,eng,1931-3543 0012-3692,United States and Patient Preference and *Decision Making and Legal Guardians/*legislation & jurisprudence and Advance Directives/*legislation & jurisprudence and Advance Care Planning/legislation & jurisprudence,NA,NA,2012/04//undefined,Chest,NA,NA,NA,NA
Freedman_2019_Ches,JOUR,Doing It Better for Less: Incorporating OSA Management Into Alternative Payment Models,"Freedman, Neil",Chest,"As the cost of health care continues to escalate, payers are adapting by moving away from models based on traditional fee-for-service reimbursement to models focused on rewarding care delivery that reduces costs and improves quality. These alternative payment models (APMs) are being introduced by government and commercial payers and will likely become the norm over time. Recent changes in sleep medicine related to advances in technology and approaches by payers for the management of OSA make this an appropriate time to incorporate the delivery of sleep medicine services into APMs. For OSA, the approaches that should lead to success include the appropriate use of home sleep apnea testing and automatic positive airway pressure; lower cost providers to manage less complex patients; evolving technologies including cloud-based positive airway pressure adherence monitoring, telemedicine, and Internet-based coaching to improve adherence with treatments; data analytics to better identify high-risk populations and to more appropriately allocate resources; and appropriate referrals of more complex cases to sleep specialists for management. All of these approaches should improve the value of care for payers, providers, and patients while allowing sleep specialists to more appropriately allocate their efforts to overseeing APM program development and administration and allowing them to focus on the management of more complicated patients.",2019,10.1016/j.chest.2018.06.033,155,1,227-233,eng,1931-3543 0012-3692,"Humans and *Models, Economic and *Health Expenditures and accountable care organizations and Delivery of Health Care/*economics and obstructive sleep apnea and sleep medicine and Accountable Care Organizations/*methods and alternative payment models and home sleep apnea testing and Sleep Apnea, Obstructive/economics/*therapy",NA,NA,2019/01//undefined,Chest,NA,NA,NA,NA
Tonelli_2010_Ches,JOUR,Compromised autonomy and the seriously ill patient,"Tonelli, Mark R. and Misak, Cheryl J.",Chest,"Respect for patient autonomy has become the preeminent principle of medical ethics, to the point that tools have been developed, such as instructive directives, in an attempt to preserve a semblance of autonomy even when it has become clearly and irretrievably lost. Much of the practice around the respect for autonomy, however, mistakenly supposes that the capacity for autonomous choice is an all-or-nothing proposition. But seriously ill patients may retain some ability to participate in discussions of medical care yet have their autonomy profoundly compromised by physical duress, cognitive dysfunction, or delirium. The choices of individuals with compromised autonomy do not carry the same moral weight as those of the fully autonomous. Clinicians, therefore, cannot rely on such choices for guiding medical decisions and are obligated to evaluate them more fully before acting. We argue that clinicians should compare the choices of individuals with compromised autonomy to a medical assessment of the patient's best interest. When the patient's choice and the best-interests assessment are discordant, acting in the patient's best interest may, at times, rightly override the requests of the patient. Such an approach, under a tightly constrained set of circumstances, would permit both the provision and the withholding of medical interventions despite patient requests to the contrary.",2010,10.1378/chest.09-1574,137,4,926-931,eng,1931-3543 0012-3692,"Humans and Patient Participation and *Ethics, Medical and *Personal Autonomy and Decision Making/*ethics and Critical Illness/*therapy and Patient Rights/ethics",NA,NA,2010/04//undefined,Chest,NA,NA,NA,NA
Wilson_2013_Ches,JOUR,Physician staffing models impact the timing of decisions to limit life support in the ICU,"Wilson, Michael E. and Samirat, Ramez and Yilmaz, Murat and Gajic, Ognjen and Iyer, Vivek N.",Chest,"BACKGROUND: A growing trend is the implementation of 24-h attending physician coverage in the ICU. Our aim was to measure the impact of 24-h, in-house, attending intensivist coverage on the quality of end-of-life care and the timing of end-of-life decision-making. METHODS: A retrospective cohort study was conducted of all ICU deaths 6 months before and 6 months after the implementation of mandatory 24-h attending intensivist coverage in a medical ICU. Data relevant to end-of-life care per established consensus recommendations were abstracted from the medical record. RESULTS: The following changes were observed after implementation of 24-h intensivist coverage: Time from ICU admission to decision to withdraw mechanical ventilation and time to decision to change to do-not-resuscitate code status both were shortened by 2 days (both P = .03). Quality measures, such as increased family presence around time of death ( P = .01) also improved. Other findings, which did not reach statistical significance, included the following: Time to family conference was shortened by 2 days ( P = .09), time to decision to limit any life support was shortened by 1 day ( P = .08), time to death was shortened by 2 days ( P = .08), and intubations against patient wishes decreased (from three to none; P = .12). CONCLUSIONS: The implementation of mandatory 24-h, in-house, attending intensivist coverage was associated with earlier decision-making across a number of domains related to end-of-life care. Positive trends were noted in quality of end-of-life care as reflected in the presence of family at the time of death.",2013,10.1378/chest.12-1173,143,3,656-663,eng,1931-3543 0012-3692,"Humans and Female and Male and Middle Aged and Retrospective Studies and Aged and Time Factors and Workforce and Minnesota and Aged, 80 and over and Respiration, Artificial and *Decision Making and Resuscitation Orders and Personnel Staffing and Scheduling/*organization & administration and Hospitals, Teaching/organization & administration and *Intensive Care Units/organization & administration and Life Support Care/*organization & administration/statistics & numerical data and Medical Staff, Hospital/*organization & administration and Terminal Care/standards",NA,NA,2013/03//undefined,Chest,NA,NA,NA,NA
Bullen_2020_Ches,JOUR,Studies of Medical Tests: Design and Analytical Considerations,"Bullen, Jennifer A.",Chest,"Medical tests are procedures intended to detect, diagnose, characterize, or monitor a specific medical condition. Understanding the accuracy of a medical test is a critical part of informed decision-making in patient management, as it allows clinicians to appreciate the types of errors a medical test might be prone to making and how often it makes them. Designing a study to assess the performance of a medical test, however, presents unique challenges, from acquiring a reference standard to dealing with the complexities that arise when the test involves an interpretation by a human reader. This article provides an overview of design considerations in this context, including common biases and how to avoid them, statistical considerations, and reporting guidelines. A short list of questions is also provided, which can serve as a quick reference for anyone designing, implementing, or reviewing a study that intends to assess the performance of a medical test.",2020,10.1016/j.chest.2020.03.006,158,1S,S103-S112,eng,1931-3543 0012-3692,"Humans and statistics and Guidelines as Topic and study design and Research Design/*statistics & numerical data and diagnostic accuracy and Diagnostic Tests, Routine/*methods/*statistics & numerical data",NA,NA,2020/07//undefined,Chest,NA,NA,NA,NA
Gries_2013_Amjoofreancrcame,JOUR,An official American Thoracic Society/International Society for Heart and Lung Transplantation/Society of Critical Care Medicine/Association of Organ and Procurement Organizations/United Network of Organ Sharing Statement: ethical and policy considerations in organ donation after circulatory determination of death,"Gries, Cynthia J. and White, Douglas B. and Truog, Robert D. and Dubois, James and Cosio, Carmen C. and Dhanani, Sonny and Chan, Kevin M. and Corris, Paul and Dark, John and Fulda, Gerald and Glazier, Alexandra K. and Higgins, Robert and Love, Robert and Mason, David P. and Nakagawa, Thomas A. and Shapiro, Ron and Shemie, Sam and Tracy, Mary Fran and Travaline, John M. and Valapour, Maryam and West, Lori and Zaas, David and Halpern, Scott D.",American journal of respiratory and critical care medicine,"RATIONALE: Donation after circulatory determination of death (DCDD) has the potential to increase the number of organs available for transplantation. Because consent and management of potential donors must occur before death, DCDD raises unique ethical and policy issues. OBJECTIVES: To develop an ethics and health policy statement on adult and pediatric DCDD relevant to critical care and transplantation stakeholders. METHODS: A multidisciplinary panel of stakeholders was convened to develop an ethics and health policy statement. The panel consisted of representatives from the American Thoracic Society, Society of Critical Care Medicine, International Society for Heart and Lung Transplantation, Association of Organ Procurement Organizations, and the United Network of Organ Sharing. The panel reviewed the literature, discussed important ethics and health policy considerations, and developed a guiding framework for decision making by stakeholders. RESULTS: A framework to guide ethics and health policy statement was established, which addressed the consent process, pre- and post mortem interventions, the determination of death, provisions of end-of-life care, and pediatric DCDD. CONCLUSIONS: The information presented in this Statement is based on the current evidence, experience, and clinical rationale. New clinical research and the development and dissemination of new technologies will eventually necessitate an update of this Statement.",2013,10.1164/rccm.201304-0714ST,188,1,103-109,eng,1535-4970 1073-449X,"United States and Humans and Adult and Child and Health Policy and *Ethics, Medical and *Death and Informed Consent/ethics and Terminal Care/ethics and Organ Transplantation/ethics and Societies, Medical/*ethics and Critical Care/ethics and Tissue and Organ Procurement/*ethics and Tissue Donors/*ethics",NA,NA,2013/07/01/,Am J Respir Crit Care Med,NA,NA,NA,NA
Rubin_2013_Ches,JOUR,Medical futility procedures: what more do we need to know?,"Rubin, Emily and Courtwright, Andrew",Chest,"Unilateral medical futility policies, which allow health-care providers to limit or withdraw life-sustaining treatment over patient or surrogate objections, are increasingly designed around a procedural approach. Medical or ethics committees follow a prespecified process, the culmination of which is a justified decision about whether ongoing treatment should be withheld or withdrawn. These procedures have three stages. First, health-care providers must decide to refer patients for consideration of whether ongoing treatment is futile. Second, the committees involved must decide whether ongoing treatment is actually futile. Third, there is a clinical outcome that often is, but not always, patient death. We review the available data on procedure-based futility policies, arguing that there is limited information on their potential harms and how these harms are distributed. We consider the ethical implications of policy-making under informational uncertainty, invoking the precautionary principle--in the absence of clear data, if a policy has significant risk of significant harm, the burden of proof that it is not harmful falls on those recommending the policy--as the guiding moral standard for hospitals and professional organizations considering whether to adopt a procedural approach to medical futility. On the basis of this principle, we argue that any new futility guideline must include a significant commitment to collecting prospective data on its application.",2013,10.1378/chest.13-1240,144,5,1707-1711,eng,1931-3543 0012-3692,Humans and *Personal Autonomy and Decision Making/*ethics and Withholding Treatment/*ethics and Medical Futility/*ethics and Refusal to Treat/*ethics,NA,NA,2013/11//undefined,Chest,NA,NA,NA,NA
Gupta_2019_TheEurresjou,JOUR,The Electronic Asthma Management System (eAMS) improves primary care asthma management,"Gupta, Samir and Price, Courtney and Agarwal, Gina and Chan, David and Goel, Sanjeev and Boulet, Louis-Philippe and Kaplan, Alan G. and Lebovic, Gerald and Mamdani, Muhammad and Straus, Sharon E.",The European respiratory journal,"A high prevalence of suboptimal asthma control is attributable to known evidence-practice gaps. We developed a computerised clinical decision support system (the Electronic Asthma Management System (eAMS)) to address major care gaps and sought to measure its impact on care in adults with asthma.This was a 2-year interrupted time-series study of usual care (year 1) versus eAMS (year 2) at three Canadian primary care sites. We included asthma patients aged <e2><89><a5>16 years receiving an asthma medication within the last 12 months. The eAMS consisted of a touch tablet patient questionnaire completed in the waiting room, with real-time data processing producing electronic medical record-integrated clinician decision support.Action plan delivery (primary outcome) improved from zero out of 412 (0%) to 79 out of 443 (17.8%) eligible patients (absolute increase 0.18 (95% CI 0.14-0.22)). Time-series analysis indicated a 30.5% increase in physician visits with action plan delivery with the intervention (p<0.0001). Assessment of asthma control level increased from 173 out of 3497 (4.9%) to 849 out of 3062 (27.7%) eligible visits (adjusted OR 8.62 (95% CI 5.14-12.45)). Clinicians escalated controller therapy in 108 out of 3422 (3.2%) baseline visits versus 126 out of 3240 (3.9%) intervention visits (p=0.12). At baseline, a short-acting <ce><b2>-agonist alone was added in 62 visits and a controller added in 54 visits; with the intervention, this occurred in 33 and 229 visits, respectively (p<0.001).The eAMS improved asthma quality of care in real-world primary care settings. Strategies to further increase clinician uptake and a randomised controlled trial to assess impact on patient outcomes are now required.",2019,10.1183/13993003.02241-2018,53,4,NA,eng,1399-3003 0903-1936,"Humans and Female and Male and Adult and Middle Aged and Primary Health Care and Prospective Studies and Treatment Outcome and *Decision Making, Computer-Assisted and Interrupted Time Series Analysis and Asthma/*therapy",NA,NA,2019/04//undefined,Eur Respir J,NA,NA,NA,NA
Loubiere_2018_TheEurresjou,JOUR,"Cost-effectiveness of KRAS, EGFR and ALK testing for decision making in advanced nonsmall cell lung carcinoma: the French IFCT-PREDICT.amm study","Loubiere, Sandrine and Drezet, Alexandre and Beau-Faller, Michele and Moro-Sibilot, Denis and Friard, Sylvie and Wislez, Marie and Blons, Helene and Daniel, Catherine and Westeel, Virginie and Madroszyk, Anne and Lena, Herve and Merle, Patrick and Mazieres, Julien and Zalcman, Gerard and Lacave, Roger and Antoine, Martine and Morin, Franck and Missy, Pascale and Barlesi, Fabrice and Auquier, Pascal and Cadranel, Jacques",The European respiratory journal,"ALK rearrangement and EGFR/KRAS mutations constitute the primary biomarkers tested to provide targeted or nontargeted therapies in advanced nonsmall cell lung cancer (NSCLC) patients. Our objective was to assess the cost-effectiveness of biomarker testing for NSCLC.Between 2013 and 2014, 843 treatment-naive patients were prospectively recruited at 19 French hospitals into a longitudinal observational cohort study. Two testing strategies were compared, i.e. with ""at least one biomarker status known"" and ""at least KRAS status known"", in addition to ""no biomarker testing"" as the reference strategy. The Kaplan-Meier approach was employed to assess restricted mean survival time. Direct medical costs incurred by hospitals were estimated with regard to treatment, inpatient care and biomarker testing.Compared with ""no biomarker testing"", the ""at least one biomarker status known"" strategy yielded an incremental cost-effectiveness ratio of EUR13 230 per life-year saved, which decreased to EUR7444 per life-year saved with the ""at least KRAS status known"" testing strategy. In sensitivity analyses, biomarker testing strategies were less costly and more effective in 41% of iterations.In summary, molecular testing prior to treatment initiation proves to be cost-effective in advanced NSCLC management and may assist decision makers in defining conditions for further implementation of these innovations in general practice.",2018,10.1183/13993003.01467-2017,51,3,1701467,eng,1399-3003 0903-1936,"Mutation and Humans and Female and Male and Adult and Middle Aged and Aged and Decision Making and Cost-Benefit Analysis and Longitudinal Studies and Aged, 80 and over and Biomarkers and France and Anaplastic Lymphoma Kinase/genetics and Carcinoma, Non-Small-Cell Lung/*economics/*genetics and DNA Mutational Analysis/*economics and ErbB Receptors/genetics and Genetic Testing/*economics and Lung Neoplasms/*economics/*genetics and Proto-Oncogene Proteins p21(ras)/genetics and Pulmonary Medicine/economics/methods",NA,NA,2018/03//undefined,Eur Respir J,NA,NA,NA,NA
Aggarwal_2011_Ches,JOUR,Simulation to enhance patient safety: why aren't we there yet?,"Aggarwal, Rajesh and Darzi, Ara",Chest,"The delivery of state-of-the-art medical care is complex, with large numbers of treatment strategies often available to individual patients. It is paramount to ensure that each patient receives optimal treatment in a safe, effective, and timely manner. Evidence suggests that an unacceptably high number of patients currently experience suboptimal care as the result of adverse events and medical error. Simulation-based training reduces medical error, enhances clinical outcomes, and reduces the cost of clinical care. It is surprising that medical simulation is not routinely integrated into the training curricula of all health-care professionals. Simulation enables doctors to practice and hone their technical, communication, decision making, and crisis management skills in a safe and educationally orientated environment. The process can foster the development of interprofessional working skills, leading to enhanced patient outcomes. Selection, credentialing, and revalidation of medical professionals are also possible in a simulation setting, enabling maintenance of standards of practice throughout a medical career. In order for simulation to become a part of the medical curriculum, collaborative efforts are required from academics, physicians, managers, and policy makers alike. Bringing these groups together, while a challenge, can lead to high-level outputs in medical care, which will benefit all.",2011,10.1378/chest.11-0728,140,4,854-858,eng,1931-3543 0012-3692,"Humans and Outcome Assessment, Health Care and Curriculum/trends and Patient Safety/*standards and Medical Errors/prevention & control and Computer Simulation/*trends and Education, Medical/methods/*trends and Professional Competence/standards and General Surgery/education",NA,NA,2011/10//undefined,Chest,NA,NA,NA,NA
Nelson_2017_Amjoofreancrcame,JOUR,The Voice of Surrogate Decision-Makers. Family Responses to Prognostic Information in Chronic Critical Illness,"Nelson, Judith E. and Hanson, Laura C. and Keller, Kristine L. and Carson, Shannon S. and Cox, Christopher E. and Tulsky, James A. and White, Douglas B. and Chai, Emily J. and Weiss, Stefanie P. and Danis, Marion",American journal of respiratory and critical care medicine,"RATIONALE: Information from clinicians about the expected course of the patient's illness is relevant and important for decision-making by surrogates for chronically critically ill patients on mechanical ventilation. OBJECTIVES: To observe how surrogates of chronically critically ill patients respond to information about prognosis from palliative care clinicians. METHODS: This was a qualitative analysis of a consecutive sample of audio-recorded meetings from a larger, multisite, randomized trial of structured informational and supportive meetings led by a palliative care physician and nurse practitioner for surrogates of patients in medical intensive care units with chronic critical illness (i.e., adults mechanically ventilated for <e2><89><a5>7 days and expected to remain ventilated and survive for <e2><89><a5>72 h). MEASUREMENTS AND MAIN RESULTS: A total of 66 audio-recorded meetings involving 51 intervention group surrogates for 43 patients were analyzed using grounded theory. Six main categories of surrogate responses to prognostic information were identified: (1) receptivity, (2) deflection/rejection, (3) emotion, (4) characterization of patient, (5) consideration of surrogate role, and (6) mobilization of support. Surrogates responded in multiple and even antithetical ways, within and across meetings. CONCLUSIONS: Prognostic disclosure by skilled clinician communicators evokes a repertoire of responses from surrogates for the chronically critically ill. Recognition of these response patterns may help all clinicians better communicate their support to patients and families facing chronic critical illness and inform interventions to support surrogate decision-makers in intensive care units. Clinical trial registered with www.clinicaltrials.gov (NCT 01230099).",2017,10.1164/rccm.201701-0201OC,196,7,864-872,eng,1535-4970 1073-449X,"Humans and Female and Male and Middle Aged and Prognosis and health communication and *Decision Making and Chronic Disease/*psychology and Family/*psychology and Palliative Care/methods/*psychology and Professional-Family Relations and palliative care and mechanical ventilation and Critical Illness/*psychology and Critical Care/methods/*psychology and critical illness and Respiration, Artificial/psychology/statistics & numerical data",NA,NA,2017/10/01/,Am J Respir Crit Care Med,NA,NA,NA,NA
Misak_2014_Ches,JOUR,Medical futility: a new look at an old problem,"Misak, Cheryl J. and White, Douglas B. and Truog, Robert D.",Chest,"Efforts to answer the question of whether or when physicians may unilaterally refuse to provide treatments they deem medically futile, but that are nonetheless demanded by patients or their surrogates, have been characterized as intractable failures. We propose a new look at this old problem and suggest reframing the debate in terms of the implicit social contract, in healthy democracies, between the medical profession and the society it serves. This ever-evolving contract is predicated upon providing patients with beneficial and desired medical care within the constraints of scarce resources and the characteristics of our health-care system. The contract ranges over a continuum of decisions, from those that do not need an explicit negotiated agreement with the patient or surrogate, to those that do. Between these two poles lies a contentious gray area, where the rights and obligations of patients and physicians are being shaped continuously by the many forces that are at play in a democratic society, including professional guidelines, social advocacy, legislation, and litigation. We provide examples of how this gray area has been and is negotiated around rights to refuse and demand a variety of life-sustaining treatments, and anticipate conflicts likely to arise in the future. Reframing the futility debate in this way reveals that the issue is not a story of intractable failure, but rather, a successful narrative about how democracies balance the legitimate perspectives of patients and physicians against a backdrop of societal constraints and values.",2014,10.1378/chest.14-0513,146,6,1667-1672,eng,1931-3543 0012-3692,"United States and Humans and Female and Male and Decision Making and Patient Selection and *Attitude of Health Personnel and Withholding Treatment/*ethics and Medical Futility/*ethics/psychology and Resource Allocation/*ethics and Practice Patterns, Physicians'/*ethics",NA,NA,2014/12//undefined,Chest,NA,NA,NA,NA
White_2009_Ches,JOUR,Terminal withdrawal of mechanical ventilation at a long-term acute care hospital: comparison with a medical ICU,"White, Alexander C. and Joseph, Bernard and Gireesh, Arvind and Shantilal, Priya and Garpestad, Erik and Hill, Nicholas S. and O'Connor, Heidi H.",Chest,"BACKGROUND: Failure to wean from prolonged mechanical ventilation (MV) is common in long-term acute care hospitals (LTACHs), but the process of terminal withdrawal of MV in LTACHs is not well described. We compared terminal withdrawal of MV at an LTACH with that in a medical ICU (MICU). METHODS: A retrospective medical chart review was done of all patients undergoing terminal withdrawal of MV in an LTACH (n = 30) and in a MICU (n = 74) over a 2-year period. RESULTS: The decision to withdraw MV was more likely initiated by patient or family in the LTACH and by medical staff in the MICU (p < 0.0001). Social workers, pastoral care, and hospital administration were more likely to participate in the withdrawal process at the LTACH compared with the MICU (p < 0.05). Time from initiation of MV to orders for do not resuscitate, comfort measures only, or withdrawal of MV was significantly greater in the LTACH (weeks) compared with the MICU (days) (p < 0.05). The dose of benzodiazepines given during the final 24 h of life was greater in the MICU as compared with the LTACH (p < 0.05). Narcotic and benzodiazepine use in the hour before or after withdrawal of MV did not differ between the two groups. COPD and pneumonia were the most common causes of death among patients undergoing withdrawal of MV at the LTACH, as opposed to septic shock in the MICU (p < 0.05). CONCLUSIONS: Terminal withdrawal of MV in the LTACH differs from that in the MICU with regard to decision making, benzodiazepine use, and cause of death.",2009,10.1378/chest.09-0085,136,2,465-470,eng,1931-3543 0012-3692,"Humans and Female and Male and Middle Aged and Retrospective Studies and Risk Assessment and Aged and Time Factors and Decision Making and Patient Participation and Physician-Patient Relations and Probability and Cohort Studies and Aged, 80 and over and Statistics, Nonparametric and Hospitals, General and *Intensive Care Units and *Long-Term Care and *Cause of Death and Terminal Care/*methods and *Withholding Treatment and Respiration, Artificial/methods and Life Support Care/standards/trends",NA,NA,2009/08//undefined,Chest,NA,NA,NA,NA
Goligher_2020_Amjoofreancrcame,JOUR,Lung- and Diaphragm-Protective Ventilation,"Goligher, Ewan C. and Dres, Martin and Patel, Bhakti K. and Sahetya, Sarina K. and Beitler, Jeremy R. and Telias, Irene and Yoshida, Takeshi and Vaporidi, Katerina and Grieco, Domenico Luca and Schepens, Tom and Grasselli, Giacomo and Spadaro, Savino and Dianti, Jose and Amato, Marcelo and Bellani, Giacomo and Demoule, Alexandre and Fan, Eddy and Ferguson, Niall D. and Georgopoulos, Dimitrios and Guerin, Claude and Khemani, Robinder G. and Laghi, Franco and Mercat, Alain and Mojoli, Francesco and Ottenheijm, Coen A. C. and Jaber, Samir and Heunks, Leo and Mancebo, Jordi and Mauri, Tommaso and Pesenti, Antonio and Brochard, Laurent",American journal of respiratory and critical care medicine,"Mechanical ventilation can cause acute diaphragm atrophy and injury, and this is associated with poor clinical outcomes. Although the importance and impact of lung-protective ventilation is widely appreciated and well established, the concept of diaphragm-protective ventilation has recently emerged as a potential complementary therapeutic strategy. This Perspective, developed from discussions at a meeting of international experts convened by PLUG (the Pleural Pressure Working Group) of the European Society of Intensive Care Medicine, outlines a conceptual framework for an integrated lung- and diaphragm-protective approach to mechanical ventilation on the basis of growing evidence about mechanisms of injury. We propose targets for diaphragm protection based on respiratory effort and patient-ventilator synchrony. The potential for conflict between diaphragm protection and lung protection under certain conditions is discussed; we emphasize that when conflicts arise, lung protection must be prioritized over diaphragm protection. Monitoring respiratory effort is essential to concomitantly protect both the diaphragm and the lung during mechanical ventilation. To implement lung- and diaphragm-protective ventilation, new approaches to monitoring, to setting the ventilator, and to titrating sedation will be required. Adjunctive interventions, including extracorporeal life support techniques, phrenic nerve stimulation, and clinical decision-support systems, may also play an important role in selected patients in the future. Evaluating the clinical impact of this new paradigm will be challenging, owing to the complexity of the intervention. The concept of lung- and diaphragm-protective ventilation presents a new opportunity to potentially improve clinical outcomes for critically ill patients.",2020,10.1164/rccm.202003-0655CP,202,7,950-961,eng,1535-4970 1073-449X,"Humans and Consensus and Decision Support Systems, Clinical and Critical Care and mechanical ventilation and artificial respiration and Diaphragm/*injuries and Electric Stimulation Therapy and Extracorporeal Membrane Oxygenation and lung injury and Muscular Atrophy/etiology/*prevention & control and myotrauma and Phrenic Nerve and Respiration, Artificial/adverse effects/*methods and Ventilator-Induced Lung Injury/etiology/*prevention & control",NA,NA,2020/10/01/,Am J Respir Crit Care Med,NA,NA,NA,NA
Bruce_2016_Ches,JOUR,Navigating Ethical Conflicts Between Advance Directives and Surrogate Decision-Makers' Interpretations of Patient Wishes,"Bruce, Courtenay R. and Bibler, Trevor and Childress, Andrew M. and Stephens, Ashley L. and Pena, Adam M. and Allen, Nathan G.",Chest,"There is little guidance on what clinicians should do when advance directives (or living wills, specifically) are challenged, particularly when surrogate decision-makers' interpretations of patients' wishes conflict with the living will. In our commentary, we make a controversial argument suggesting that overriding living wills can be ethically preferable to the alternative of strictly adhering to them. We propose four ethical considerations for determining whether it is ethically supportable to override living wills.",2016,10.1378/chest.15-2209,149,2,562-567,eng,1931-3543 0012-3692,Humans and Morals and quality of life and *Decision Making and critical care and medical ethics and end of life and Terminal Care/*ethics and Advance Directives/*ethics and commentary and Living Wills/*ethics,NA,NA,2016/02//undefined,Chest,NA,NA,NA,NA
Sprung_2014_Amjoofreancrcame,JOUR,Seeking worldwide professional consensus on the principles of end-of-life care for the critically ill. The Consensus for Worldwide End-of-Life Practice for Patients in Intensive Care Units (WELPICUS) study,"Sprung, Charles L. and Truog, Robert D. and Curtis, J. Randall and Joynt, Gavin M. and Baras, Mario and Michalsen, Andrej and Briegel, Josef and Kesecioglu, Jozef and Efferen, Linda and De Robertis, Edoardo and Bulpa, Pierre and Metnitz, Philipp and Patil, Namrata and Hawryluck, Laura and Manthous, Constantine and Moreno, Rui and Leonard, Sara and Hill, Nicholas S. and Wennberg, Elisabet and McDermid, Robert C. and Mikstacki, Adam and Mularski, Richard A. and Hartog, Christiane S. and Avidan, Alexander",American journal of respiratory and critical care medicine,"Great differences in end-of-life practices in treating the critically ill around the world warrant agreement regarding the major ethical principles. This analysis determines the extent of worldwide consensus for end-of-life practices, delineates where there is and is not consensus, and analyzes reasons for lack of consensus. Critical care societies worldwide were invited to participate. Country coordinators were identified and draft statements were developed for major end-of-life issues and translated into six languages. Multidisciplinary responses using a web-based survey assessed agreement or disagreement with definitions and statements linked to anonymous demographic information. Consensus was prospectively defined as >80% agreement. Definitions and statements not obtaining consensus were revised based on comments of respondents, and then translated and redistributed. Of the initial 1,283 responses from 32 countries, consensus was found for 66 (81%) of the 81 definitions and statements; 26 (32%) had >90% agreement. With 83 additional responses to the original questionnaire (1,366 total) and 604 responses to the revised statements, consensus could be obtained for another 11 of the 15 statements. Consensus was obtained for informed consent, withholding and withdrawing life-sustaining treatment, legal requirements, intensive care unit therapies, cardiopulmonary resuscitation, shared decision making, medical and nursing consensus, brain death, and palliative care. Consensus was obtained for 77 of 81 (95%) statements. Worldwide consensus could be developed for the majority of definitions and statements about end-of-life practices. Statements achieving consensus provide standards of practice for end-of-life care; statements without consensus identify important areas for future research.",2014,10.1164/rccm.201403-0593CC,190,8,855-866,eng,1535-4970 1073-449X,Humans and International Cooperation and Decision Making and Critical Illness and intensive care unit and end-of-life decisions and cardiopulmonary resuscitation and Informed Consent/ethics/standards and Brain Death and do-not-resuscitate orders and Critical Care/ethics/methods/*standards and Terminal Care/ethics/methods/*standards and Withholding Treatment/ethics/standards and Intensive Care Units/ethics/standards and Palliative Care/ethics/methods/standards and withholding and withdrawing life-sustaining treatment,NA,NA,2014/10/15/,Am J Respir Crit Care Med,NA,NA,NA,NA
Dingfield_2017_Ches,JOUR,Integrating Advance Care Planning Into Practice,"Dingfield, Laura E. and Kayser, Joshua B.",Chest,"Advanced respiratory diseases progress over time and often lead to death. As the condition worsens, patients may lose medical decision-making ability. Advance care planning (ACP) is a process in which patients receive information about their diagnosis and prognosis; discuss values, goals, and fears; articulate preferences about life-sustaining treatments and end-of-life care; and appoint a surrogate medical decision maker. This process may result in written documentation of patient preferences or the appointment of a health-care power of attorney (HCPOA). ACP discussions have multiple benefits for patients and their surrogate decision makers, including ensuring that the care provided is aligned with the patient's goals and preferences and decreasing stress, anxiety, and burden in surrogates. Time and provider comfort are often cited barriers to ACP, so it may be necessary for clinicians to gain experience in conversations and identify the patients most likely to benefit from ACP discussions. Two new Current Procedural Terminology (CPT) codes, 99497 and 99498, have been recognized by the Centers for Medicare and Medicaid Services (CMS) as of January 1, 2016 and are intended to incentivize clinicians to engage in ACP discussions with their patients earlier and with more frequency. This manuscript reviews the benefits and barriers to ACP in patients with advanced respiratory disease and provides guidance on the use of the new CPT codes for reimbursement of these conversations.",2017,10.1016/j.chest.2017.02.024,151,6,1387-1393,eng,1931-3543 0012-3692,"Humans and Delivery of Health Care and Decision Making and Anxiety and Stress, Psychological and coding and Advance Directives and Patient Preference and Clinical Coding and Reimbursement Mechanisms and *Terminal Care and *Advance Care Planning and Proxy and advance care planning and *Pulmonary Medicine and advanced respiratory disease and billing and Respiratory Tract Diseases/*therapy",NA,NA,2017/06//undefined,Chest,NA,NA,NA,NA
Biesbroek_2014_Amjoofreancrcame,JOUR,Early respiratory microbiota composition determines bacterial succession patterns and respiratory health in children,"Biesbroek, Giske and Tsivtsivadze, Evgeni and Sanders, Elisabeth A. M. and Montijn, Roy and Veenhoven, Reinier H. and Keijser, Bart J. F. and Bogaert, Debby",American journal of respiratory and critical care medicine,"RATIONALE: Many bacterial pathogens causing respiratory infections in children are common residents of the respiratory tract. Insight into bacterial colonization patterns and microbiota stability at a young age might elucidate healthy or susceptible conditions for development of respiratory disease. OBJECTIVES: To study bacterial succession of the respiratory microbiota in the first 2 years of life and its relation to respiratory health characteristics. METHODS: Upper respiratory microbiota profiles of 60 healthy children at the ages of 1.5, 6, 12, and 24 months were characterized by 16S-based pyrosequencing. We determined consecutive microbiota profiles by machine-learning algorithms and validated the findings cross-sectionally in an additional cohort of 140 children per age group. MEASUREMENTS AND MAIN RESULTS: Overall, we identified eight distinct microbiota profiles in the upper respiratory tract of healthy infants. Profiles could already be identified at 1.5 months of age and were associated with microbiota stability and change over the first 2 years of life. More stable patterns were marked by early presence and high abundance of Moraxella and Corynebacterium/Dolosigranulum and were positively associated with breastfeeding in the first period of life and with lower rates of parental-reported respiratory infections in the consecutive periods. Less stable profiles were marked by high abundance of Haemophilus or Streptococcus. CONCLUSIONS: These findings provide novel insights into microbial succession in the respiratory tract in infancy and link early-life profiles to microbiota stability and respiratory health characteristics. New prospective studies should elucidate potential implications of our findings for early diagnosis and prevention of respiratory infections. Clinical trial registered with www.clinicaltrials.gov (NCT00189020).",2014,10.1164/rccm.201407-1240OC,190,11,1283-1292,eng,1535-4970 1073-449X,"Humans and Child, Preschool and Infant and children and Anti-Bacterial Agents and Age Distribution and Netherlands and Breast Feeding and Disease Susceptibility and Microbiota/*physiology and Bacteria/*isolation & purification and Bronchodilator Agents/therapeutic use and Corynebacterium/isolation & purification/physiology and microbial communities and microbiota and Moraxella/isolation & purification/physiology and Nasopharynx/*microbiology and respiratory tract and Respiratory Tract Infections/drug therapy/*microbiology and succession",NA,NA,2014/12/01/,Am J Respir Crit Care Med,NA,NA,NA,NA
Kattan_2020_Ches,JOUR,A Framework for the Evaluation of Statistical Prediction Models,"Kattan, Michael W. and Gerds, Thomas A.",Chest,"We have entered the era of ""big data"" and with that the explosion of interest in prediction modeling. With this explosion comes the challenge of evaluating statistical prediction models, both from the standpoint of an author as well as a reviewer. This article provides guidance for the evaluation and critique of a statistical prediction model. Hopefully, this will improve the quality of statistical prediction modeling studies and facilitate their review.",2020,10.1016/j.chest.2020.03.005,158,1S,S29-S38,eng,1931-3543 0012-3692,"Humans and outcomes and *Models, Statistical and Forecasting/*methods and medical decision-making and *Evaluation Studies as Topic and Research Design/*statistics & numerical data and prediction models",NA,NA,2020/07//undefined,Chest,NA,NA,NA,NA
Capers_2020_Ches,JOUR,Bias and Racism Teaching Rounds at an Academic Medical Center,"Capers, Quinn 4th and Bond, David A. and Nori, Uday S.",Chest,"Racism and events of racial violence have dominated the US news in 2020 almost as much as the novel coronavirus pandemic. The resultant civil unrest and demands for racial justice have spawned a global call for change. As a subset of a society that struggles with racism and other explicit biases, it is inescapable that some physicians and health-care employees will have the same explicit biases as the general population. Patients who receive care at academic medical centers interact with multiple individuals, some of whom may have explicit and implicit biases that influence patient care. In fact, multiple reports have documented that some physicians, health-care workers, and health professional students have negative biases based on race, ethnicity, obesity, religion, and sexual identity, among others. These biases can influence decision-making and aggravate health-care disparities and patient-physician mistrust. We review four actual cases from academic medical centers that illustrate how well-intended physicians and health-care workers can be influenced by bias and how this can put patients at risk. Strategies to mitigate bias are discussed and recommended. We introduce what we believe can be a powerful teaching tool: periodic ""bias and racism rounds"" in teaching hospitals, in which real patient interactions are reviewed critically to identify opportunities to reduce bias and racism and to attenuate the impact of bias and racism on patient outcomes.",2020,10.1016/j.chest.2020.08.2073,158,6,2688-2694,eng,1931-3543 0012-3692,strategy and Humans and Healthcare Disparities and Physician-Patient Relations and bias and Prejudice and *Attitude of Health Personnel and *Racism and racism and *Academic Medical Centers and *Teaching Rounds,NA,NA,2020/12//undefined,Chest,NA,NA,NA,NA
Vandvik_2013_Ches,JOUR,"Creating clinical practice guidelines we can trust, use, and share: a new era is imminent","Vandvik, Per Olav and Brandt, Linn and Alonso-Coello, Pablo and Treweek, Shaun and Akl, Elie A. and Kristiansen, Annette and Fog-Heen, Anja and Agoritsas, Thomas and Montori, Victor M. and Guyatt, Gordon",Chest,"Standards and guidance for developing trustworthy clinical practice guidelines are now available, and a number of leading guidelines adhere to the key standards. Even current trustworthy guidelines, however, generally suffer from a cumbersome development process, suboptimal presentation formats, inefficient dissemination to clinicians at the point of care, high risk of becoming quickly outdated, and suboptimal facilitation of shared decision-making with patients. To address these limitations, we have--in our innovative research program and nonprofit organization, MAGIC (Making GRADE the Irresistible Choice)--constructed a conceptual framework and tools to facilitate the creation, dissemination, and dynamic updating of trustworthy guidelines. We have developed an online application that constitutes an authoring and publication platform that allows guideline content to be written and structured in a database, published directly on our web platform or exported in a computer-interpretable language (eg, XML) enabling dissemination through a wide range of outputs that include electronic medical record systems, web portals, and applications for smartphones/tablets. Modifications in guidelines, such as recommendation updates, will lead to automatic alterations in these outputs with minimal additional labor for guideline authors and publishers, greatly facilitating dynamic updating of guidelines. Semiautomated creation of a new generation of decision aids linked to guideline recommendations should facilitate face-to-face shared decision-making in the clinical encounter. We invite guideline organizations to partner with us (www.magicproject.org) to apply and further improve the tools for their purposes. This work will result in clinical practice guidelines that we cannot only trust, but also easily share and use.",2013,10.1378/chest.13-0746,144,2,381-389,eng,1931-3543 0012-3692,"Humans and Quality Assurance, Health Care and Evidence-Based Medicine and Diffusion of Innovation and Internet and User-Computer Interface and Decision Support Techniques and Interprofessional Relations and *Publishing and *Decision Making and *Authorship and Practice Guidelines as Topic/*standards",NA,NA,2013/08//undefined,Chest,NA,NA,NA,NA
Kajdacsy.Balla.Amaral_2014_Amjoofreancrcame,JOUR,Nighttime cross-coverage is associated with decreased intensive care unit mortality. A single-center study,"Kajdacsy-Balla Amaral, Andre Carlos and Barros, Bernardo S. and Barros, Camilla C. P. P. and Innes, Cameron and Pinto, Ruxandra and Rubenfeld, Gordon D.",American journal of respiratory and critical care medicine,"RATIONALE: Cross-coverage is associated with medical errors caused by miscommunication during handoffs. However, no direct evidence links handoffs to outcomes, or explains the mechanisms leading to outcomes. Furthermore, the previous literature may overestimate the impact of handoffs because of hindsight bias. OBJECTIVES: To explore the effects of nighttime cross-coverage on mortality and decision making in critically ill patients. METHODS: Observational cohort of 629 consecutive critically ill admissions, admitted for at least 48 hours, and critical care fellows in an academic hospital. MEASUREMENTS AND MAIN RESULTS: Intensive care unit (ICU) mortality and nighttime decisions. Our exposure variable was cross-covering status of fellows. We observed a decrease in ICU mortality (odds ratio, 0.77 per 1 d; 0.60-0.99; P = 0.04), a higher number of nighttime decisions (19.3 vs. 10.4%; odds ratio, 2.02; 95% confidence interval [CI], 1.03-3.95; P = 0.04), an increase in fentanyl equivalents administered to patients at night (difference, +10.2 <ce><bc>g/h; 95% CI, +1.4 to +19.0; P = 0.02), and an increase in transfusions at night (difference, +465 ml; 95% CI, +98 to +832; P = 0.01) when fellows were cross-covering. CONCLUSIONS: In this single-center study exposure to cross-covering fellows was associated with a decrease in ICU mortality and with more nighttime decisions. Our findings contradict the dominant hypothesis that cross-coverage is associated with worse outcomes, and suggest that a ""second look"" by cross-covering fellows may mitigate cognitive errors. Future interventions to improve patient safety in ICUs should focus both on the quality of handoffs and on strategies to decrease cognitive errors.",2014,10.1164/rccm.201312-2181OC,189,11,1395-1401,eng,1535-4970 1073-449X,"Humans and Female and Male and Adult and Middle Aged and Aged and Cohort Studies and Aged, 80 and over and Hospitals, University and Intensive Care Units/*statistics & numerical data and Canada/epidemiology and *Hospital Mortality and Critical Illness/*mortality and Length of Stay/statistics & numerical data and *Personnel Staffing and Scheduling and Internship and Residency/statistics & numerical data and *Night Care/statistics & numerical data and After-Hours Care/*statistics & numerical data and Fellowships and Scholarships/statistics & numerical data and Medical Staff, Hospital/*statistics & numerical data and Respiration, Artificial/mortality",NA,NA,2014/06/01/,Am J Respir Crit Care Med,NA,NA,NA,NA
Walkey_2017_Amjoofreancrcame,JOUR,Accounting for Patient Preferences Regarding Life-Sustaining Treatment in Evaluations of Medical Effectiveness and Quality,"Walkey, Allan J. and Barnato, Amber E. and Wiener, Renda Soylemez and Nallamothu, Brahmajee K.",American journal of respiratory and critical care medicine,"The importance of understanding patient preferences for life-sustaining treatment is well described for individual clinical decisions; however, its role in evaluations of healthcare outcomes and quality has received little attention. Decisions to limit life-sustaining therapies are strongly associated with high risks for death in ways that are unaccounted for by routine measures of illness severity. However, this essential information is generally unavailable to researchers, with the potential for spurious inferences. This may lead to ""confounding by unmeasured patient preferences"" (a type of confounding by indication) and has implications for assessments of treatment effectiveness and healthcare quality, especially in acute and critical care settings in which risk for death and adverse events are high. Through a collection of case studies, we explore the effect of unmeasured patient resuscitation preferences on issues critical for researchers and research consumers to understand. We then propose strategies to more consistently elicit, record, and harmonize documentation of patient preferences that can be used to attenuate confounding by unmeasured patient preferences and provide novel opportunities to improve the patient centeredness of medical care for serious illness.",2017,10.1164/rccm.201701-0165CP,196,8,958-963,eng,1535-4970 1073-449X,"United States and Humans and Female and Male and Adult and Middle Aged and Aged and Decision Making and Treatment Outcome and Aged, 80 and over and Quality of Life/*psychology and quality of healthcare and Patient Satisfaction/*statistics & numerical data and Patient Preference/*psychology and Quality of Health Care/*statistics & numerical data and end-of-life care and Advance Care Planning/*standards/*statistics & numerical data and epidemiologic biases",NA,NA,2017/10/15/,Am J Respir Crit Care Med,NA,NA,NA,NA
Schnapp_2020_Ches,JOUR,Basic Primer for Finances in Academic Adult and Pediatric Pulmonary Divisions,"Schnapp, Lynn M. and Steiner, Michael J. and Davis, Stephanie D.",Chest,"The finances of academic medical centers (AMCs) are complex and rapidly evolving. This financial environment can have important effects on faculty expectations, compensation, and the work environment. This article describes the commonly used concepts and models related to financial decision-making in Pulmonology and Critical Care divisions across AMCs in the United States. Faculty clinical productivity is often measured by work relative value units, which are set nationally for a discrete piece of physician work and attempt to equilibrate aspects of care across specialties. The expected clinical productivity and salary for a given faculty member are often determined relative to one or more national benchmarks developed from data submitted by departments and schools across the country. The most commonly used benchmarks include those from the Association of American Medical Colleges and the Medical Group Management Association. Changes to the paradigm of fee for service reimbursement are beginning to change physician compensation and incentive structures. In addition, research and education are key academic missions for faculty. It is important to understand the limitations of extramural research funding and implications for the support of research infrastructure. Measurements of productivity within education have been less codified, but some centers are attempting to create educational relative value units similar to those used in clinical productivity. In summary, faculty should understand basic concepts of finances. This knowledge includes a common set of terms and concepts that can help all faculty understand basic financial considerations in their work and lead to success for their divisions.",2020,10.1016/j.chest.2019.09.019,157,2,363-368,eng,1931-3543 0012-3692,"United States and Humans and Reimbursement, Incentive and Adult and Efficiency and Child and Fee-for-Service Plans and Research Support as Topic and Faculty, Medical and Reimbursement Mechanisms and *Financial Management and clinical practice and Salaries and Fringe Benefits and Relative Value Scales and Academic Medical Centers/*economics and Critical Care/*economics and finance and Pediatrics/economics and pulmonary division and Pulmonary Medicine/*economics",NA,NA,2020/02//undefined,Chest,NA,NA,NA,NA
Kouri_2020_Ches,JOUR,Addressing Reduced Laboratory-Based Pulmonary Function Testing During a Pandemic,"Kouri, Andrew and Gupta, Samir and Yadollahi, Azadeh and Ryan, Clodagh M. and Gershon, Andrea S. and To, Teresa and Tarlo, Susan M. and Goldstein, Roger S. and Chapman, Kenneth R. and Chow, Chung-Wai",Chest,"To reduce the spread of the severe acute respiratory syndrome coronavirus 2, many pulmonary function testing (PFT) laboratories have been closed or have significantly reduced their testing capacity. Because these mitigation strategies may be necessary for the next 6 to 18 months to prevent recurrent peaks in disease prevalence, fewer objective measurements of lung function will alter the diagnosis and care of patients with chronic respiratory diseases. PFT, which includes spirometry, lung volume, and diffusion capacity measurement, is essential to the diagnosis and management of patients with asthma, COPD, and other chronic lung conditions. Both traditional and innovative alternatives to conventional testing must now be explored. These may include peak expiratory flow devices, electronic portable spirometers, portable exhaled nitric oxide measurement, airwave oscillometry devices, and novel digital health tools such as smartphone microphone spirometers and mobile health technologies along with integration of machine learning approaches. The adoption of some novel approaches may not merely replace but could improve existing management strategies and alter common diagnostic paradigms. With these options comes important technical, privacy, ethical, financial, and medicolegal barriers that must be addressed. However, the coronavirus disease 19 pandemic also presents a unique opportunity to augment conventional testing by including innovative and emerging approaches to measuring lung function remotely in patients with respiratory disease. The benefits of such an approach have the potential to enhance respiratory care and empower patient self-management well beyond the current global pandemic.",2020,10.1016/j.chest.2020.06.065,158,6,2502-2510,eng,1931-3543 0012-3692,"SARS-CoV-2 and Humans and Chronic Disease and Machine Learning and review and asthma and Peak Expiratory Flow Rate and Smartphone and Delivery of Health Care/*methods and *COVID-19 and Inventions and COVID-19 pandemic and Self-Management and COPD and Asthma/diagnosis/physiopathology/therapy and Breath Tests/instrumentation/methods and Cystic Fibrosis/diagnosis/therapy and Hypertension, Pulmonary/diagnosis/therapy and Lung Diseases, Interstitial/diagnosis/therapy and Lung Diseases/*diagnosis/physiopathology/*therapy and Lung Volume Measurements and Oscillometry/instrumentation/methods and Pulmonary Diffusing Capacity/instrumentation/methods and Pulmonary Disease, Chronic Obstructive/diagnosis/physiopathology/therapy and pulmonary function test and Respiratory Function Tests/*instrumentation/*methods and Spirometry/instrumentation/methods",NA,NA,2020/12//undefined,Chest,NA,NA,NA,NA
Bhattacharjee_2017_Ches,JOUR,Identifying Patients With Sepsis on the Hospital Wards,"Bhattacharjee, Poushali and Edelson, Dana P. and Churpek, Matthew M.",Chest,"Sepsis contributes to up to half of all deaths in hospitalized patients, and early interventions, such as appropriate antibiotics, have been shown to improve outcomes. Most research has focused on early identification and treatment of patients with sepsis in the ED and the ICU; however, many patients acquire sepsis on the general wards. The goal of this review is to discuss recent advances in the detection of sepsis in patients on the hospital wards. We discuss data highlighting the benefits and limitations of the systemic inflammatory response syndrome (SIRS) criteria for screening patients with sepsis, such as its low specificity, as well as newly described scoring systems, including the proposed role of the quick sepsis-related organ failure assessment (qSOFA) score. Challenges specific to detecting sepsis on the wards are discussed, and future directions that use big data approaches and automated alert systems are highlighted.",2017,10.1016/j.chest.2016.06.020,151,4,898-907,eng,1931-3543 0012-3692,"Humans and Hospital Mortality and sepsis and Diagnosis, Differential and *Hospitalization and *Decision Support Systems, Clinical and Organ Dysfunction Scores and clinical decision support systems and Sepsis/*diagnosis/mortality and SIRS and SOFA and Systemic Inflammatory Response Syndrome/diagnosis/mortality",NA,NA,2017/04//undefined,Chest,NA,NA,NA,NA
Sullivan_2012_Ches,JOUR,"Learned helplessness among families and surrogate decision-makers of patients admitted to medical, surgical, and trauma ICUs","Sullivan, Donald R. and Liu, Xinggang and Corwin, Douglas S. and Verceles, Avelino C. and McCurdy, Michael T. and Pate, Drew A. and Davis, Jennifer M. and Netzer, Giora",Chest,"BACKGROUND: We sought to determine the prevalence of and clinical variables associated with learned helplessness, a psychologic state characterized by reduced motivation, difficulty in determining causality, and depression, in family members of patients admitted to ICUs. METHODS: We conducted an observational survey study of a prospectively defined cohort of family members, spouses, and partners of patients admitted to surgical, medical, and trauma ICUs at a large academic medical center. Two validated instruments, the Learned Helplessness Scale and the Perceived Stress Scale, were used, and self-report of patient clinical characteristics and subject demographics were collected. RESULTS: Four hundred ninety-nine family members were assessed. Of these, 238 of 460 (51.7%) had responses consistent with a significant degree of learned helplessness. Among surrogate decision-makers, this proportion was 50% (92 of 184). Characteristics associated with significant learned helplessness included grade or high school education (OR, 3.27; 95% CI, 1.29-8.27; P = .01) and Perceived Stress Scale score > 18 (OR, 4.15; 95% CI, 2.65-6.50; P < .001). The presence of a patient advance directive or do not resuscitate (DNR) order was associated with reduced odds of significant learned helplessness (OR, 0.56; 95% CI, 0.32-0.98; P = .05). CONCLUSIONS: The majority of family members of patients in the ICU experience significant learned helplessness. Risk factors for learned helplessness include lower educational levels, absence of an advance directive or DNR order, and higher stress levels among family members. Significant learned helplessness in family members may have negative implications in the collaborative decision-making process.",2012,10.1378/chest.12-0112,142,6,1440-1446,eng,1931-3543 0012-3692,"Humans and Data Collection and Female and Male and Adult and Middle Aged and Aged and Surveys and Questionnaires and Educational Status and Psychological Tests and Cohort Studies and Prospective Studies and Risk Factors and Self Report and *Decision Making and *Intensive Care Units and Family/*psychology and *Inpatients and Advance Directives/psychology and *Helplessness, Learned and Depression/epidemiology/*psychology",NA,NA,2012/12//undefined,Chest,NA,NA,NA,NA
Lustbader_2012_Ches,JOUR,Physician reimbursement for critical care services integrating palliative care for patients who are critically ill,"Lustbader, Dana R. and Nelson, Judith E. and Weissman, David E. and Hays, Ross M. and Mosenthal, Anne C. and Mulkerin, Colleen and Puntillo, Kathleen A. and Ray, Daniel E. and Bassett, Rick and Boss, Renee D. and Brasel, Karen J. and Campbell, Margaret L. and Cortez, Therese B. and Curtis, J. Randall",Chest,"Patients with advanced illness often spend time in an ICU, while nearly one-third of patients with advanced cancer who receive Medicare die in hospitals, often with failed ICU care. For most, death occurs following the withdrawal or withholding of life-sustaining treatments. The integration of palliative care is essential for high-quality critical care. Although palliative care specialists are becoming increasingly available, intensivists and other physicians are also expected to provide basic palliative care, including symptom treatment and communication about goals of care. Patients who are critically ill are often unable to make decisions about their care. In these situations, physicians must meet with family members or other surrogates to determine appropriate medical treatments. These meetings require clinical expertise to ensure that patient values are explored for medical decision making about therapeutic options, including palliative care. Meetings with families take time. Issues related to the disease process, prognosis, and treatment plan are complex, and decisions about the use or limitation of intensive care therapies have life-or-death implications. Inadequate reimbursement for physician services may be a barrier to the optimal delivery of high-quality palliative care, including effective communication. Appropriate documentation of time spent integrating palliative and critical care for patients who are critically ill can be consistent with the Current Procedural Terminology codes (99291 and 99292) for critical care services. The purpose of this article is to help intensivists and other providers understand the circumstances in which integration of palliative and critical care meets the definition of critical care services for billing purposes.",2012,10.1378/chest.11-2012,141,3,787-792,eng,1931-3543 0012-3692,"United States and Humans and Quality of Health Care and Decision Making and Insurance, Health, Reimbursement/*economics and Bereavement and Palliative Care/*economics and Critical Care/*economics and Clinical Coding/standards and Critical Illness/*economics and Insurance, Physician Services/*economics and Medicare/*economics",NA,NA,2012/03//undefined,Chest,NA,NA,NA,NA
MacLean_2012_Ches,JOUR,"Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","MacLean, Samantha and Mulla, Sohail and Akl, Elie A. and Jankowski, Milosz and Vandvik, Per Olav and Ebrahim, Shanil and McLeod, Shelley and Bhatnagar, Neera and Guyatt, Gordon H.",Chest,"BACKGROUND: Development of clinical practice guidelines involves making trade-offs between desirable and undesirable consequences of alternative management strategies. Although the relative value of health states to patients should provide the basis for these trade-offs, few guidelines have systematically summarized the relevant evidence. We conducted a systematic review relating to values and preferences of patients considering antithrombotic therapy. METHODS: We included studies examining patient preferences for alternative approaches to antithrombotic prophylaxis and studies that examined, in the context of antithrombotic prophylaxis or treatment, how patients value alternative health states and experiences with treatment. We conducted a systematic search and compiled structured summaries of the results. Steps in the process that involved judgment were conducted in duplicate. RESULTS: We identified 48 eligible studies. Sixteen dealt with atrial fibrillation, five with VTE, four with stroke or myocardial infarction prophylaxis, six with thrombolysis in acute stroke or myocardial infarction, and 17 with burden of antithrombotic treatment. CONCLUSION: Patient values and preferences regarding thromboprophylaxis treatment appear to be highly variable. Participant responses may depend on their prior experience with the treatments or health outcomes considered as well as on the methods used for preference elicitation. It should be standard for clinical practice guidelines to conduct systematic reviews of patient values and preferences in the specific content area.",2012,10.1378/chest.11-2290,141,2 Suppl,e1S-e23S,eng,1931-3543 0012-3692,"United States and Humans and Patient Satisfaction and Cost of Illness and Societies, Medical and *Decision Making and *Evidence-Based Medicine and *Practice Guidelines as Topic and *Patient Participation and *Patient Preference and *Social Values and Atrial Fibrillation/complications/drug therapy and Fibrinolytic Agents/adverse effects/*therapeutic use and Myocardial Infarction/drug therapy/prevention & control and Stroke/drug therapy/prevention & control and Thrombolytic Therapy/adverse effects and Thrombosis/*drug therapy/*prevention & control and Venous Thromboembolism/drug therapy/prevention & control",NA,NA,2012/02//undefined,Chest,NA,NA,NA,NA
Diamond_2010_Ches,JOUR,Electronic medical records: a practitioner's perspective on evaluation and implementation,"Diamond, Edward and French, Kim and Gronkiewicz, Cynthia and Borkgren, Marilyn",Chest,"This article describes the initial and ongoing efforts of our pulmonary medicine practice to deploy an electronic medical records (EMR) system. Key factors in the vendor selection and implementation process included (1) identification and commitment to long-term goals for EMR; (2) dedicated resources, including both physician and nonphysician champions to lead the design and implementation teams; and (3) ample patience and time allotted to achieve the desired results: a fully functional system that enhances quality, improves operational efficiency, and reduces costs. An EMR scorecard including multiple system attributes was designed to facilitate vendor comparisons. Perseverance, patience, and compromise were necessary to overcome the challenge of changing the behavior of providers and support staff. We have accomplished improvements in workflow automation and reductions in staff hours, office supplies, file space, and transcription costs. Our system lacks pulmonary-specific templates and prompts for work flow and clinical decision making. We have directed internal resources and outsourced professional support to design these features as our practice strives to enhance our quality of care with pulmonary disease management that conforms to national guidelines.",2010,10.1378/chest.09-1328,138,3,716-723,eng,1931-3543 0012-3692,United States and Humans and *Attitude of Health Personnel and Electronic Health Records/*organization & administration and Pulmonary Medicine/*organization & administration,NA,NA,2010/09//undefined,Chest,NA,NA,NA,NA
Bosslet_2015_Amjoofreancrcame,JOUR,An Official ATS/AACN/ACCP/ESICM/SCCM Policy Statement: Responding to Requests for Potentially Inappropriate Treatments in Intensive Care Units,"Bosslet, Gabriel T. and Pope, Thaddeus M. and Rubenfeld, Gordon D. and Lo, Bernard and Truog, Robert D. and Rushton, Cynda H. and Curtis, J. Randall and Ford, Dee W. and Osborne, Molly and Misak, Cheryl and Au, David H. and Azoulay, Elie and Brody, Baruch and Fahy, Brenda G. and Hall, Jesse B. and Kesecioglu, Jozef and Kon, Alexander A. and Lindell, Kathleen O. and White, Douglas B.",American journal of respiratory and critical care medicine,"BACKGROUND: There is controversy about how to manage requests by patients or surrogates for treatments that clinicians believe should not be administered. PURPOSE: This multisociety statement provides recommendations to prevent and manage intractable disagreements about the use of such treatments in intensive care units. METHODS: The recommendations were developed using an iterative consensus process, including expert committee development and peer review by designated committees of each of the participating professional societies (American Thoracic Society, American Association for Critical Care Nurses, American College of Chest Physicians, European Society for Intensive Care Medicine, and Society of Critical Care). MAIN RESULTS: The committee recommends: (1) Institutions should implement strategies to prevent intractable treatment conflicts, including proactive communication and early involvement of expert consultants. (2) The term ""potentially inappropriate"" should be used, rather than futile, to describe treatments that have at least some chance of accomplishing the effect sought by the patient, but clinicians believe that competing ethical considerations justify not providing them. Clinicians should explain and advocate for the treatment plan they believe is appropriate. Conflicts regarding potentially inappropriate treatments that remain intractable despite intensive communication and negotiation should be managed by a fair process of conflict resolution; this process should include hospital review, attempts to find a willing provider at another institution, and opportunity for external review of decisions. When time pressures make it infeasible to complete all steps of the conflict-resolution process and clinicians have a high degree of certainty that the requested treatment is outside accepted practice, they should seek procedural oversight to the extent allowed by the clinical situation and need not provide the requested treatment. (3) Use of the term ""futile"" should be restricted to the rare situations in which surrogates request interventions that simply cannot accomplish their intended physiologic goal. Clinicians should not provide futile interventions. (4) The medical profession should lead public engagement efforts and advocate for policies and legislation about when life-prolonging technologies should not be used. CONCLUSIONS: The multisociety statement on responding to requests for potentially inappropriate treatments in intensive care units provides guidance for clinicians to prevent and manage disputes in patients with advanced critical illness.",2015,10.1164/rccm.201505-0924ST,191,11,1318-1330,eng,1535-4970 1073-449X,"Humans and shared decision making and Societies, Medical and Critical Care/*standards and Unnecessary Procedures/*standards and Intensive Care Units/*standards and ethics committees and end-of-life care and futility and conflict resolution",NA,NA,2015/06/01/,Am J Respir Crit Care Med,NA,NA,NA,NA
Luce_2013_Ches,JOUR,"Chronic disorders of consciousness following coma: Part two: ethical, legal, and social issues","Luce, John M.",Chest,"Increasing numbers of patients survive traumatic brain injury and cardiopulmonary arrest and resuscitation and are admitted to the ICU while in coma. Some of these patients become brain dead; others regain consciousness. Still others become vegetative or minimally conscious, conditions called chronic disorders of consciousness and ultimately can be cared for outside the ICU. Whether these patients would want life-sustaining therapy is difficult to determine because most have not articulated their wishes before becoming comatose. Ethics and law recognize that patients with decision-making capacity have a right to refuse such therapy and that surrogates can exercise this right for them through the principle of substituted judgment as was established by the Supreme Court of New Jersey in the case of Karen Ann Quinlan. In its decision regarding Nancy Cruzan, the US Supreme Court determined that states may require clear and convincing evidence of a vegetative patient's prior wishes before life-sustaining therapy may be withdrawn; this standard has been applied to minimally conscious patients by state supreme courts in some cases. Nevertheless, cases such as these only come to the legal system because end-of-life decisions are contested, which is unusual, and most end-of-life decisions for specific patients with chronic disorders of consciousness are made by surrogates with recommendations from physicians without court involvement. Recent advances in neuroimaging may influence both end-of-life decision-making and legal deliberations. Targeting vegetative and minimally conscious patients in medical resource allocation remains ethically unacceptable and untested in the law.",2013,10.1378/chest.13-0428,144,4,1388-1393,eng,1931-3543 0012-3692,Humans and Chronic Disease and Sociology and Bioethical Issues/*legislation & jurisprudence and Coma/*complications and Persistent Vegetative State/diagnosis/*etiology,NA,NA,2013/10//undefined,Chest,NA,NA,NA,NA
Aulisio_2008_Ches,JOUR,Role of the ethics committee: helping to address value conflicts or uncertainties,"Aulisio, Mark P. and Arnold, Robert M.",Chest,"This article addresses two basic questions about ethics committees: why we have them, and how they might be helpful to clinicians. Our answer to the first question is twofold. First, we suggest that legal, regulatory, and professional forces drove the development of ethics committees, particularly as an alternative to litigation. Second, we argue that ethics committees arose in response to a clinical need for a formal mechanism to address some of the value conflicts and uncertainties that arise in contemporary health-care settings. We argue that this need, reflected in early high-profile legal cases, stems partly from the complex value-laden nature of clinical decision making, a pluralistic societal context, a growing recognition of the rights of individuals to live by their values, and the relevance of those values for medical decision making. In answer to the second question, we draw out three ways ethics committees might be helpful to clinicians: education, policy formation or review, and consultation. We devote the majority of our discussion to ethics consultation and its relation to the emerging area of palliative care. In so doing, we highlight three important differences: (1) the scope or range of cases for which they may be appropriate, (2) focus in any particular case, and (3) general orientation-between ethics consultation and palliative care that clinicians should take into account in deciding to seek the assistance of either or both.",2008,10.1378/chest.08-0136,134,2,417-424,eng,0012-3692,"Humans and Policy Making and Ethics Consultation and Ethics, Clinical/education and Dissent and Disputes/legislation & jurisprudence and Ethics Committees, Clinical/*organization & administration and Professional Misconduct/ethics/legislation & jurisprudence",NA,NA,2008/08//undefined,Chest,NA,NA,NA,NA
Scott_2020_Ches,JOUR,Airway Management in Critical Illness: An Update,"Scott, J. Aaron and Heard, Stephen O. and Zayaruzny, Maksim and Walz, J. Matthias",Chest,"Expertise in airway management is a vital skill for any provider caring for critically ill patients. A growing body of literature has identified the stark difference in periprocedural outcomes of elective intubation in the operating room when compared with emergency intubation in the ICU. A number of strategies to reduce the morbidity and mortality associated with airway management in the critically ill have been described. In this review, we provide an updated framework for airway assessment before direct laryngoscopy and video laryngoscopy, and use of newer pharmacologic agents; comment on current concepts in tracheal intubation in the ICU; and address human factors around critical decision-making during ICU airway management.",2020,10.1016/j.chest.2019.10.026,157,4,877-887,eng,1931-3543 0012-3692,"Humans and *Emergency Medical Services and Critical Illness/*therapy and airway management and Laryngoscopy/methods and *Airway Management/methods/trends and difficult airway and ICU intubation and Intubation, Intratracheal/methods",NA,NA,2020/04//undefined,Chest,NA,NA,NA,NA
Daly_2010_Ches,JOUR,Effectiveness trial of an intensive communication structure for families of long-stay ICU patients,"Daly, Barbara J. and Douglas, Sara L. and O'Toole, Elizabeth and Gordon, Nahida H. and Hejal, Rana and Peerless, Joel and Rowbottom, James and Garland, Allan and Lilly, Craig and Wiencek, Clareen and Hickman, Ronald",Chest,"BACKGROUND: Formal family meetings have been recommended as a useful approach to assist in goal setting, facilitate decision making, and reduce use of ineffective resources in the ICU. We examined patient outcomes before and after implementation of an intensive communication system (ICS) to test the effect of regular, structured formal family meetings on patient outcomes among long-stay ICU patients. METHODS: One hundred thirty-five patients receiving usual care and communication were enrolled as the control group, followed by enrollment of intervention patients (n = 346), from five ICUs. The ICS included a family meeting within 5 days of ICU admission and weekly thereafter. Each meeting discussed medical update, values and preferences, and goals of care; treatment plan; and milestones for judging effectiveness of treatment. RESULTS: Using multivariate analysis, there were no significant differences between control and intervention patients in length of stay (LOS), the primary end point. Similarly, there were no significant differences in indicators of aggressiveness of care or treatment limitation decisions (ICU mortality, LOS, duration of ventilation, treatment limitation orders, or use of tracheostomy or percutaneous gastrostomy). Exploratory analysis suggested that in the medical ICUs, the intervention was associated with a lower prevalence of tracheostomy among patients who died or had do-not-attempt-resuscitation orders in place. CONCLUSIONS: The negative findings of the main analysis, in combination with preliminary evidence of differences among types of unit, suggest that further examination of the influence of patient, family, and unit characteristics on the effects of a system of regular family meetings may be warranted. Despite the lack of influence on patient outcomes, structured family meetings may be an effective approach to meeting information and support needs. TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT01057238 ; URL: www.clinicaltrials.gov.",2010,10.1378/chest.10-0292,138,6,1340-1348,eng,1931-3543 0012-3692,Humans and Female and Male and Adult and Middle Aged and Risk Assessment and Aged and Decision Making and Multivariate Analysis and Treatment Outcome and Length of Stay and Survival Analysis and Observer Variation and Total Quality Management and Long-Term Care and *Communication and Patient Care Planning/*organization & administration and *Intensive Care Units and *Professional-Family Relations and Critical Care/*methods and Critical Illness/mortality/therapy,NA,NA,2010/12//undefined,Chest,NA,NA,NA,NA
Peters_2020_Ches,JOUR,New Billing Rules for Outpatient Office Visit Codes,"Peters, Steve G.",Chest,"Guidelines for clinical documentation of evaluation and management face-to-face services were developed > 20 years ago. Recently, the Centers for Medicare & Medicaid Services (CMS) have addressed office and other outpatient services and the corresponding reimbursement, intending to reduce the amount of required documentation and to alleviate clerical burden. A CMS final rule for 2021 will eliminate the history and physical examination as criteria for level of service, allow time or medical decision-making to be used as coding criteria, and will recognize a code for prolonged service. The net effect of these changes may be some decrease in documentation burden, a change in the composition of clinical notes, and greater recognition by CMS of primary care and those who see highly complex patients requiring prolonged services.",2020,10.1016/j.chest.2020.01.028,158,1,298-302,eng,1931-3543 0012-3692,United States and Humans and Time Factors and *Medicare and *Documentation and *Ambulatory Care and *Medicaid and *Office Visits and *Reimbursement Mechanisms and CPT coding and Current Procedural Terminology and evaluation and management and topics in practice management,NA,NA,2020/07//undefined,Chest,NA,NA,NA,NA
Biddison_2014_Ches,JOUR,Ethical considerations: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement,"Biddison, Lee Daugherty and Berkowitz, Kenneth A. and Courtney, Brooke and De Jong, Col Marla J. and Devereaux, Asha V. and Kissoon, Niranjan and Roxland, Beth E. and Sprung, Charles L. and Dichter, Jeffrey R. and Christian, Michael D. and Powell, Tia",Chest,"BACKGROUND: Mass critical care entails time-sensitive decisions and changes in the standard of care that it is possible to deliver. These circumstances increase provider uncertainty as well as patients' vulnerability and may, therefore, jeopardize disciplined, ethical decision-making. Planning for pandemics and disasters should incorporate ethics guidance to support providers who may otherwise make ad hoc patient care decisions that overstep ethical boundaries. This article provides consensus-developed suggestions about ethical challenges in caring for the critically ill or injured during pandemics or disasters. The suggestions in this article are important for all of those involved in any pandemic or disaster with multiple critically ill or injured patients, including front-line clinicians, hospital administrators, and public health or government officials. METHODS: We adapted the American College of Chest Physicians (CHEST) Guidelines Oversight Committee's methodology to develop suggestions. Twenty-four key questions were developed, and literature searches were conducted to identify evidence for suggestions. The detailed literature reviews produced 144 articles. Based on their expertise within this domain, panel members also supplemented the literature search with governmental publications, interdisciplinary workgroup consensus documents, and other information not retrieved through PubMed. The literature in this field is not suitable to support evidence-based recommendations. Therefore, the panel developed expert opinion-based suggestions using a modified Delphi process. RESULTS: We report the suggestions that focus on five essential domains: triage and allocation, ethical concerns of patients and families, ethical responsibilities to providers, conduct of research, and international concerns. CONCLUSIONS: Ethics issues permeate virtually all aspects of pandemic and disaster response. We have addressed some of the most pressing issues, focusing on five essential domains: triage and allocation, ethical concerns of patients and families, ethical responsibilities to providers, conduct of research, and international concerns. Our suggestions reflect the consensus of the Task Force. We recognize, however, that some suggestions, including those related to end-of-life care, may be controversial. We highlight the need for additional research and dialogue in articulating values to guide health-care decisions during disasters.",2014,10.1378/chest.14-0742,146,4 Suppl,55S-e145S,eng,1931-3543 0012-3692,Humans and *Consensus and *Pandemics and Decision Making/ethics and Critical Illness/*therapy and *Disasters and Emergency Medical Services/*ethics and Triage/*ethics and Wounds and Injuries/*therapy,NA,NA,2014/10//undefined,Chest,NA,NA,NA,NA
Curley_2012_Amjoofreancrcame,JOUR,Parent presence during invasive procedures and resuscitation: evaluating a clinical practice change,"Curley, Martha A. Q. and Meyer, Elaine C. and Scoppettuolo, Lisa A. and McGann, Elizabeth A. and Trainor, Bethany P. and Rachwal, Christine M. and Hickey, Patricia A.",American journal of respiratory and critical care medicine,"RATIONALE: Parent presence during invasive procedures and/or resuscitation is a relatively underdeveloped and controversial practice. Much of the concern stems from the apprehension of the medical community. OBJECTIVES: To evaluate whether implementation of formal practice guidelines and corresponding interprofessional education would improve clinicians' sense of preparation and comfort in providing parents with options during their children's procedures. METHODS: Multiphase pre-post survey of (1) clinician perceptions and (2) practice from the perspective of clinicians and parents experiencing the same procedure. Data were collected over 4 years from a cardiovascular and critical care program in one U.S. children's hospital. MEASUREMENTS AND MAIN RESULTS: More than 70% of clinicians participated in the perception surveys (n = 782) and 538 clinicians and 274 parents participated in the practice surveys. After the intervention, clinicians reported that parents were present during more invasive procedures and reported higher levels of comfort with the practice of providing options to parents during resuscitative events. Levels of comfort were higher in clinicians who had practiced skills in a simulated learning environment. During both phases, few clinicians reported that parent presence affected their technical performance (4%), therapeutic decision-making (5%), or ability to teach (9%). During the post phase, clinicians reported more active parent behaviors during procedures. Parents who reported receiving information to help them prepare for their children's procedures reported higher levels of procedural understanding and emotional support. CONCLUSIONS: Implementation of practice guidelines and interprofessional education had a positive impact on clinicians' perceptions and practice when providing parents with options and support during their children's invasive procedures and/or resuscitation.",2012,10.1164/rccm.201205-0915OC,186,11,1133-1139,eng,1535-4970 1073-449X,"Humans and Female and Male and Child and Child, Preschool and Cross-Sectional Studies and Practice Guidelines as Topic and Chi-Square Distribution and Statistics, Nonparametric and Hospitals, Pediatric and Parent-Child Relations and *Attitude of Health Personnel and Parents/*psychology and *Intensive Care Units, Pediatric and Visitors to Patients/*psychology and Critical Care/organization & administration and Resuscitation/*methods/psychology",NA,NA,2012/12/01/,Am J Respir Crit Care Med,NA,NA,NA,NA
Will_2011_Ches_1,JOUR,A brief historical and theoretical perspective on patient autonomy and medical decision making: Part II: The autonomy model,"Will, Jonathan F.",Chest,"As part of a larger series addressing the intersection of law and medicine, this essay is the second of two introductory pieces. Beginning with the Hippocratic tradition and lasting for the next 2,400 years, the physician-patient relationship remained relatively unchanged under the beneficence model, a paternalistic framework characterized by the authoritative physician being afforded maximum discretion by the trusting, obedient patient. Over the last 100 years or so, in response to certain changes taking place in both research and clinical practice, the bioethics movement ushered in the autonomy model, and with it, a profoundly different way of approaching decision making in medicine. The shift from the beneficence model to the autonomy model is governed legally by the informed consent doctrine, which emphasizes disclosure to patients of information sufficient to permit them to make intelligent choices regarding treatment alternatives. As this legal doctrine became established, philosophers identified an inherent value in respecting patients as autonomous agents, even where patient choice seems to conflict with the physician's duty to act in the patient's best interests. Whereas the beneficence model presumed that the physician knew what was in the patient's best interests, the autonomy model starts from the premise that the patient knows what treatment decision is in line with his or her true sense of well-being, even where that decision is the refusal of treatment and the result is the patient's death.",2011,10.1378/chest.11-0516,139,6,1491-1497,eng,1931-3543 0012-3692,"United States and Humans and History, 20th Century and *Personal Autonomy and History, 19th Century and Patient Rights/ethics/*history/legislation & jurisprudence and Informed Consent/ethics/*history/legislation & jurisprudence and Patient Participation/*history/legislation & jurisprudence",NA,NA,2011/06//undefined,Chest,NA,NA,NA,NA
Bosch_2017_Amjoofreancrcame,JOUR,"Maturation of the Infant Respiratory Microbiota, Environmental Drivers, and Health Consequences. A Prospective Cohort Study","Bosch, Astrid A. T. M. and de Steenhuijsen Piters, Wouter A. A. and van Houten, Marlies A. and Chu, Mei Ling J. N. and Biesbroek, Giske and Kool, Jolanda and Pernet, Paula and de Groot, Pieter-Kees C. M. and Eijkemans, Marinus J. C. and Keijser, Bart J. F. and Sanders, Elisabeth A. M. and Bogaert, Debby",American journal of respiratory and critical care medicine,"RATIONALE: Perinatal and postnatal influences are presumed important drivers of the early-life respiratory microbiota composition. We hypothesized that the respiratory microbiota composition and development in infancy is affecting microbiota stability and thereby resistance against respiratory tract infections (RTIs) over time. OBJECTIVES: To investigate common environmental drivers, including birth mode, feeding type, antibiotic exposure, and crowding conditions, in relation to respiratory tract microbiota maturation and stability, and consecutive risk of RTIs over the first year of life. METHODS: In a prospectively followed cohort of 112 infants, we characterized the nasopharyngeal microbiota longitudinally from birth on (11 consecutive sample moments and the maximum three RTI samples per subject; in total, n = 1,121 samples) by 16S-rRNA gene amplicon sequencing. MEASUREMENTS AND MAIN RESULTS: Using a microbiota-based machine-learning algorithm, we found that children experiencing a higher number of RTIs in the first year of life already demonstrate an aberrant microbial developmental trajectory from the first month of life on as compared with the reference group (0-2 RTIs/yr). The altered microbiota maturation process coincided with decreased microbial community stability, prolonged reduction of Corynebacterium and Dolosigranulum, enrichment of Moraxella very early in life, followed by later enrichment of Neisseria and Prevotella spp. Independent drivers of these aberrant developmental trajectories of respiratory microbiota members were mode of delivery, infant feeding, crowding, and recent antibiotic use. CONCLUSIONS: Our results suggest that environmental drivers impact microbiota development and, consequently, resistance against development of RTIs. This supports the idea that microbiota form the mediator between early-life environmental risk factors for and susceptibility to RTIs over the first year of life.",2017,10.1164/rccm.201703-0554OC,196,12,1582-1590,eng,1535-4970 1073-449X,"Humans and Female and Male and Child and Infant and Longitudinal Studies and Cohort Studies and Prospective Studies and development and risk factors and Microbiota/*physiology and Anti-Bacterial Agents/therapeutic use and Netherlands/epidemiology and Delivery, Obstetric/statistics & numerical data and *Environment and Nasopharynx/*microbiology and Breast Feeding/statistics & numerical data and Infant Food/statistics & numerical data and nasopharynx and respiratory microbiota and respiratory tract infections and Respiratory Tract Infections/*epidemiology",NA,NA,2017/12/15/,Am J Respir Crit Care Med,NA,NA,NA,NA
Courtney_2014_Ches,JOUR,Legal preparedness: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement,"Courtney, Brooke and Hodge, James G. Jr and Toner, Eric S. and Roxland, Beth E. and Penn, Matthew S. and Devereaux, Asha V. and Dichter, Jeffrey R. and Kissoon, Niranjan and Christian, Michael D. and Powell, Tia",Chest,"BACKGROUND: Significant legal challenges arise when health-care resources become scarce and population-based approaches to care are implemented during severe disasters and pandemics. Recent emergencies highlight the serious legal, economic, and health impacts that can be associated with responding in austere conditions and the critical importance of comprehensive, collaborative health response system planning. This article discusses legal suggestions developed by the American College of Chest Physicians (CHEST) Task Force for Mass Critical Care to support planning and response efforts for mass casualty incidents involving critically ill or injured patients. The suggestions in this chapter are important for all of those involved in a pandemic or disaster with multiple critically ill or injured patients, including front-line clinicians, hospital administrators, and public health or government officials. METHODS: Following the CHEST Guidelines Oversight Committee's methodology, the Legal Panel developed 35 key questions for which specific literature searches were then conducted. The literature in this field is not suitable to provide support for evidence-based recommendations. Therefore, the panel developed expert opinion-based suggestions using a modified Delphi process resulting in seven final suggestions. RESULTS: Acceptance is widespread for the health-care community's duty to appropriately plan for and respond to severe disasters and pandemics. Hospitals, public health entities, and clinicians have an obligation to develop comprehensive, vetted plans for mass casualty incidents involving critically ill or injured patients. Such plans should address processes for evacuation and limited appeals and reviews of care decisions. To legitimize responses, deter independent actions, and trigger liability protections, mass critical care (MCC) plans should be formally activated when facilities and practitioners shift to providing MCC. Adherence to official MCC plans should contribute to protecting hospitals and practitioners who act in good faith from liability. Finally, to address anticipated staffing shortages during severe and prolonged disasters and pandemics, governments should develop approaches to formally expand the availability of qualified health-care workers, such as through using official foreign medical teams. CONCLUSIONS: As a fundamental element of health-care and public health emergency planning and preparedness, the law underlies critical aspects of disaster and pandemic responses. Effective responses require comprehensive advance planning efforts that include assessments of complex legal issues and authorities. Recent disasters have shown that although law is a critical response tool, it can also be used to hold health-care stakeholders who fail to appropriately plan for or respond to disasters and pandemics accountable for resulting patient or staff harm. Claims of liability from harms allegedly suffered during disasters and pandemics cannot be avoided altogether. However, appropriate planning and legal protections can help facilitate sound, consistent decision-making and support response participation among health-care entities and practitioners.",2014,10.1378/chest.14-0741,146,4 Suppl,44S-e134S,eng,1931-3543 0012-3692,Humans and Decision Making and *Consensus and *Pandemics and Emergency Medical Services/*organization & administration and Critical Illness/*therapy and *Disasters and Wounds and Injuries/*therapy and Critical Care/*legislation & jurisprudence,NA,NA,2014/10//undefined,Chest,NA,NA,NA,NA
Gerstel_2008_Amjoofreancrcame,JOUR,Duration of withdrawal of life support in the intensive care unit and association with family satisfaction,"Gerstel, Eric and Engelberg, Ruth A. and Koepsell, Thomas and Curtis, J. Randall",American journal of respiratory and critical care medicine,"RATIONALE: Most deaths in the intensive care unit (ICU) involve withholding or withdrawing multiple life-sustaining therapies, but little is known about how to proceed practically and how this process affects family satisfaction. OBJECTIVES: To examine the duration of life-support withdrawal and its association with overall family satisfaction with care in the ICU. METHODS: We studied family members of 584 patients who died in an ICU at 1 of 14 hospitals after withdrawal of life support and for whom complete medical chart and family questionnaires were available. MEASUREMENTS AND MAIN RESULTS: Data concerning six life-sustaining interventions administered during the last 5 days of life were collected. Families were asked to rate their satisfaction with care using the Family Satisfaction in the ICU questionnaire. For nearly half of the patients (271/584), withdrawal of all life-sustaining interventions took more than 1 day. Patients with a prolonged (>1 d) life-support withdrawal were younger, stayed longer in the ICU, had more life-sustaining interventions, had less often a diagnosis of cancer, and had more decision makers involved. Among patients with longer ICU stays, a longer duration in life-support withdrawal was associated with an increase in family satisfaction with care (P = 0.037). Extubation before death was associated with higher family satisfaction with care (P = 0.009). CONCLUSIONS: Withdrawal of life support is a complex process that depends on patient and family characteristics. Stuttering withdrawal is a frequent phenomenon that seems to be associated with family satisfaction. Extubation before death should be encouraged if possible.",2008,10.1164/rccm.200711-1617OC,178,8,798-804,eng,1535-4970 1073-449X,"Humans and Female and Male and Adult and Middle Aged and Aged and Decision Making and Surveys and Questionnaires and Aged, 80 and over and Follow-Up Studies and Family/*psychology and Intensive Care Units/*ethics and Professional-Family Relations/*ethics and *Withholding Treatment and Life Support Care/methods/*psychology",NA,NA,2008/10/15/,Am J Respir Crit Care Med,NA,NA,NA,NA
Gerritsen_2013_Ches,JOUR,Perception by family members and ICU staff of the quality of dying and death in the ICU: a prospective multicenter study in The Netherlands,"Gerritsen, Rik T. and Hofhuis, Jose G. M. and Koopmans, Matty and van der Woude, Meta and Bormans, Laura and Hovingh, Aly and Spronk, Peter E.",Chest,"OBJECTIVE: Admission to the ICU is a major event in a patient's life and also for family members. We tried to elucidate how family members and ICU caregivers experience the dying process of their patients. METHODS: The prospective study took place in three Dutch ICUs. Patients who had stayed . 48 h and died in the ICU were eligible. The Quality of Dying and Death (QODD) questionnaire was used, with addition of items pertaining to the patient's autonomy. Values indicate median and interquartile range. RESULTS: We included 100 consecutive patients. ICU stay before death was 8 (3-16) days. APACHE (Acute Physiology and Chronic Health Evaluation) II score at admission was 24 (19-31). Family response rate was 89%. Families were satisfied with overall QODD (score, 8 [7-9]) and felt supported by the ICU caregivers (8 [7-9]). Pain control was scored lower by family members (8 [5.75- 8.25]) than by nurses and physicians (9 [8-10], P 5 .024) Almost always, physicians discussed the patient's end-of-life wishes with family members, although families rated the quality of the discussion lower (7 [5.5-8.5]) than physicians (9 [6.5-10]) ( P 5 .045). The majority of the families (89%) felt included in the decision-making process. More than one-half of the family members (57%) believed that the physician made the fi nal decision alone after giving information, whereas 36.8% believed they had participated in making the decision. Family members rated the QODD questionnaire as difficult (6 [5-8]), and several items were not answered by a majority of family members. CONCLUSIONS: Quality of dying and death is generally perceived to be good by family members and caregivers of patients who die in Dutch ICUs. There is a need for modification of the QODD questionnaire for the European ICU population.",2013,10.1378/chest.12-0569,143,2,357-363,eng,1931-3543 0012-3692,"Humans and Female and Male and Middle Aged and Aged and Decision Making and Surveys and Questionnaires and Prospective Studies and Aged, 80 and over and Netherlands and APACHE and *Hospital Mortality and *Intensive Care Units and Family/*psychology and *Perception and Quality of Health Care/*standards and Medical Staff/*psychology",NA,NA,2013/02/01/,Chest,NA,NA,NA,NA
Curtis_2008_Ches,JOUR,Practical guidance for evidence-based ICU family conferences,"Curtis, J. Randall and White, Douglas B.",Chest,"Because most critically ill patients lack decision-making capacity, physicians often ask family members to act as surrogates for the patient in discussions about the goals of care. Therefore, clinician-family communication is a central component of medical decision making in the ICU, and the quality of this communication has direct bearing on decisions made regarding care for critically ill patients. In addition, studies suggest that clinician-family communication can also have profound effects on the experiences and long-term mental health of family members. The purpose of this narrative review is to provide a context and rationale for improving the quality of communication with family members and to provide practical, evidence-based guidance on how to conduct this communication in the ICU setting. We emphasize the importance of discussing prognosis effectively, the key role of the integrated interdisciplinary team in this communication, and the importance of assessing spiritual needs and addressing barriers that can be raised by cross-cultural communication. We also discuss the potential value of protocols to encourage communication and the potential role of quality improvement for enhancing communication with family members. Last, we review issues regarding physician reimbursement for communication with family members within the context of the US health-care system. Communication with family members in the ICU setting is complex, and high-quality communication requires training and collaboration of a well-functioning interdisciplinary team. This communication also requires a balance between adhering to processes of care that are associated with improved outcomes and individualizing communication to the unique needs of the family.",2008,10.1378/chest.08-0235,134,4,835-843,eng,0012-3692 1931-3543,Humans and Evidence-Based Medicine and Patient Participation and Practice Guidelines as Topic and *Communication and *Family Relations and *Professional-Family Relations and Critical Care/*organization & administration,NA,NA,2008/10//undefined,Chest,NA,NA,NA,NA
Lobo_2017_Ches,JOUR,Decision-Making on Withholding or Withdrawing Life Support in the ICU: A Worldwide Perspective,"Lobo, Suzana M. and De Simoni, Flavio H. B. and Jakob, Stephan M. and Estella, Angel and Vadi, Sonali and Bluethgen, Andreas and Martin-Loeches, Ignacio and Sakr, Yasser and Vincent, Jean-Louis",Chest,"BACKGROUND: Many critically ill patients who die will do so after a decision has been made to withhold/withdraw life-sustaining therapy. The objective of this study was to document the characteristics of ICU patients with a decision to withhold/withdraw life-sustaining treatment, including the types of supportive treatments used, patterns of organ dysfunction, and international differences, including gross national income (GNI). METHODS: In this observational cohort study conducted in 730 ICUs in 84 countries, all adult patients admitted between May 8, 2012, and May 18, 2012 (except admissions for routine postoperative surveillance), were included. RESULTS: The analysis included 9,524 patients, with a hospital mortality of 24%. A decision to withhold/withdraw life-sustaining treatment was reported during the ICU stay in 1,259 patients (13%), including 820 (40%) nonsurvivors and 439 (5%) survivors. Hospital mortality in patients with a decision to withhold/withdraw life-sustaining treatment was 69%. The proportion of deaths in patients with a decision to withhold/withdraw life-sustaining treatment ranged from 10% in South Asia to 67% in Oceania. Decisions to withhold/withdraw life-sustaining treatment were less frequent in low/lower-middle GNI countries than in high GNI countries (6% vs 14%; P < .001). Greater disease severity, presence of <e2><89><a5> 2 organ failures, severe comorbidities, medical and trauma admissions, and admission from the ED or hospital floor were independent predictors of a decision to withhold/withdraw life-sustaining treatment. CONCLUSIONS: There is considerable worldwide variability in decisions to withhold/withdraw life-sustaining treatments. Interestingly, almost one-third of patients with a decision to withhold/withdraw life-sustaining treatment left the hospital alive.",2017,10.1016/j.chest.2017.04.176,152,2,321-329,eng,1931-3543 0012-3692,"decision-making and Humans and Female and Male and Middle Aged and ethics and Cohort Studies and Prognosis and Global Health and end-of-life and Clinical Decision-Making/ethics and Life Support Care/ethics/*statistics & numerical data and Terminal Care/ethics/*statistics & numerical data and Critical Care/ethics/*statistics & numerical data and Withholding Treatment/ethics/*statistics & numerical data and Intensive Care Units/ethics/statistics & numerical data and Respiration, Artificial/ethics/statistics & numerical data",NA,NA,2017/08//undefined,Chest,NA,NA,NA,NA
Gores_2014_Ches,JOUR,Survival following investigational treatment of amanita mushroom poisoning: thistle or shamrock?,"Gores, Kathryn M. and Hamieh, Tarek S. and Schmidt, Gregory A.",Chest,"We report the first case, to our knowledge, of amatoxin hepatotoxicity in Iowa and explore the ethical and decisional challenges of offering an investigational treatment of a rare disease. Acute liver failure due to ingestion of amatoxin-containing mushrooms is a relatively rare entity. Once amatoxin poisoning is identified, there is no clearly effective treatment, leading to a broad range of theoretically beneficial, anecdotally successful, or investigational options. The evolution of hepatotoxicity led us to offer investigational treatment with silibinin, an extract of Mediterranean milk thistle. We explore the pitfalls in medical decision-making experienced by both the patient and the physician in the face of ambiguity. The patient did well following silibinin infusion, but we are left uncertain as to whether the patient truly responded to treatment or was simply destined to recover.",2014,10.1378/chest.13-1573,146,4,e126-e129,eng,1931-3543 0012-3692,"Survival and Humans and Male and Aged and Treatment Outcome and Acute Kidney Injury/*drug therapy/mortality and Amanita and Antioxidants/*therapeutic use and Liver Failure, Acute/*drug therapy/mortality and Mushroom Poisoning/*drug therapy/mortality and Silybin and Silymarin/*therapeutic use",NA,NA,2014/10//undefined,Chest,NA,NA,NA,NA
Johnson_2011_Amjoofreancrcame,JOUR,An empirical study of surrogates' preferred level of control over value-laden life support decisions in intensive care units,"Johnson, Sara K. and Bautista, Christopher A. and Hong, Seo Yeon and Weissfeld, Lisa and White, Douglas B.",American journal of respiratory and critical care medicine,"RATIONALE: Despite ongoing ethical debate concerning who should control decisions to discontinue life support for incapacitated, critically ill patients, the perspectives of surrogate decision makers are poorly understood. OBJECTIVES: To determine (1) what degree of decisional authority surrogates prefer for value-sensitive life support decisions compared with more technical biomedical decisions, and (2) what predicts surrogates' preferences for more control over life support decisions. METHODS: This was a prospective study of 230 surrogate decision makers for incapacitated, mechanically ventilated patients at high risk of death. Surrogates reported their preferred degree of decisional authority using the Degner Control Preferences Scale for two types of decisions: a value-sensitive decision about whether to discontinue life support and a decision regarding which antibiotic to prescribe for an infection. MEASUREMENTS AND MAIN RESULTS: The majority of surrogates (55%, 127/230; 95% confidence interval, 49-62%) preferred to have final control over the value-sensitive life support decision; 40% (91/230) wished to share control equally with the physician; 5% (12/230) of surrogates wanted the physician to make the decision. Surrogates preferred significantly more control over the value-sensitive life support decision compared with the technical decision about choice of antibiotics (P < 0.0001). Factors independently associated with surrogates' preference for more control over the life support decision were: less trust in the intensive care unit physician, male sex, and non-Catholic religious affiliation. CONCLUSIONS: Surrogates vary in their desire for decisional authority for value-sensitive life support decisions, but prefer substantially more authority for this type of decision compared with technical, medical judgments. Low trust in physicians is associated with surrogates preferring more control of life support decisions.",2011,10.1164/rccm.201008-1214OC,183,7,915-921,eng,1535-4970 1073-449X,Humans and Female and Male and Adult and Middle Aged and Aged and Multivariate Analysis and Cohort Studies and Prospective Studies and Odds Ratio and Informed Consent and Decision Making/*ethics and *Professional-Family Relations and *Proxy and Withholding Treatment/ethics and Intensive Care Units/*ethics and Critical Illness/therapy and Life Support Care/*ethics and Critical Care/ethics/methods,NA,NA,2011/04/01/,Am J Respir Crit Care Med,NA,NA,NA,NA
Zier_2009_Ches,JOUR,Surrogate decision makers' responses to physicians' predictions of medical futility,"Zier, Lucas S. and Burack, Jeffrey H. and Micco, Guy and Chipman, Anne K. and Frank, James A. and White, Douglas B.",Chest,"BACKGROUND: Although physicians sometimes use the futility rationale to limit the use of life-sustaining treatments, little is known about how surrogate decision makers view this rationale. We sought to determine the attitudes of surrogates of patients who are critically ill toward whether physicians can predict futility and whether these attitudes predict surrogates' willingness to discontinue life support when faced with predictions of futility. METHODS: This multicenter, mixed qualitative and quantitative study took place at three hospitals in California from 2006 to 2007. We conducted semistructured interviews with surrogate decision makers for 50 patients who were critically ill and incapacitated that addressed their beliefs about medical futility and inductively developed an organizing framework to describe these beliefs. We used a hypothetical scenario with a modified time-trade-off design to examine the relationship between a patient's prognosis and a surrogate's willingness to withdraw life support. We used a mixed-effects regression model to examine the association between surrogates' attitudes about futility and their willingness to limit life support in the face of a very poor prognosis. Validation methods included the use and integration of multiple data sources, multidisciplinary analysis, and member checking. RESULTS: Sixty-four percent of surrogates (n = 32; 95% confidence interval [CI], 49 to 77%) expressed doubt about the accuracy of physicians' futility predictions, 32% of surrogates (n = 16; 95% CI, 20 to 47%) elected to continue life support with a < 1% survival estimate, and 18% of surrogates (n = 9; 95% CI, 9 to 31%) elected to continue treatment when the physician believed that the patient had no chance of survival. Surrogates with religious objections to the futility rationale (n = 18) were more likely to request continued life support (odds ratio, 4; 95% CI, 1.2 to 14.0; p = 0.03) than those with secular or experiential objections (n = 15; odds ratio, 0.95; 95% CI, 0.3 to 3.4; p = 0.90). CONCLUSIONS: Doubt about physicians' ability to predict medical futility is common among surrogate decision makers. The nature of the doubt may have implications for responding to conflicts about futility in clinical practice.",2009,10.1378/chest.08-2753,136,1,110-117,eng,1931-3543 0012-3692,"Humans and Female and Male and Middle Aged and Aged and Cohort Studies and Attitude and Reproducibility of Results and Aged, 80 and over and *Decision Making and Physicians/*psychology and Caregivers/*psychology and *Critical Care and *Withholding Treatment and Medical Futility/*psychology",NA,NA,2009/07//undefined,Chest,NA,NA,NA,NA
Martinez.Balzano_2017_Ches,JOUR,An Educational Intervention Optimizes the Use of Arterial Blood Gas Determinations Across ICUs From Different Specialties: A Quality-Improvement Study,"Martinez-Balzano, Carlos D. and Oliveira, Paulo and O'Rourke, Michelle and Hills, Luanne and Sosa, Andres F.",Chest,"BACKGROUND: Overuse of arterial blood gas (ABG) determinations leads to increased costs, inefficient use of staff work hours, and patient discomfort and blood loss. We developed guidelines to optimize ABG use in the ICU. METHODS: ABG use guidelines were implemented in all adult ICUs in our institution: three medical, two trauma-surgery, one cardiovascular, and one neurosurgical ICU. Although relying on pulse oximetry, we encouraged the use of ABG determination after an acute respiratory event or for a rational clinical concern and discouraged obtaining ABG measurements for routine surveillance, after planned changes of positive end-expiratory pressure or Fio(2) on the mechanical ventilator, for spontaneous breathing trials, or when a disorder was not suspected. ABG measurements and global ICU metrics were collected before (year 2014) and after (year 2015) the intervention. RESULTS: We saw a reduction of 821.5 <c2><b1> 257.4 ABG determinations per month (41.5%), or approximately one ABG determination per patient per mechanical ventilation (MV) day for each month (43.1%), after introducing the guidelines (P < .001). This represented 49 L of saved blood, a reduction of $39,432 in the costs of ICU care, and 1,643 staff work hours freed for other tasks. Appropriately indicated tests rose to 83.4% from a baseline 67.5% (P = .002). Less than 5% of inappropriately indicated ABG determinations changed patient management in the postintervention period. There were no significant differences in MV days, severity of illness, or ICU mortality between the two periods. CONCLUSIONS: The large scale implementation of guidelines for ABG use reduced the number of inappropriately ordered ABG determinations over seven different multidisciplinary ICUs, without negatively impacting patient care.",2017,10.1016/j.chest.2016.10.035,151,3,579-585,eng,1931-3543 0012-3692,"decision-making and education and Humans and quality improvement and Critical Care/*standards and Oximetry and Respiration, Artificial and Inservice Training and *Practice Guidelines as Topic and Clinical Decision-Making and *Intensive Care Units and critical care and *Quality Improvement and Guideline Adherence/*statistics & numerical data and Hypoxia/*diagnosis and Acid-Base Imbalance/*diagnosis and Blood Gas Analysis/*statistics & numerical data and blood gases",NA,NA,2017/03//undefined,Chest,NA,NA,NA,NA
Schuetz_2012_Ches,JOUR,Role of procalcitonin in managing adult patients with respiratory tract infections,"Schuetz, Philipp and Amin, Devendra N. and Greenwald, Jeffrey L.",Chest,"Respiratory infections remain the most common reason why patients seek medical care in ambulatory and hospital settings, and they are the most frequent precursor of sepsis. In light of the limitations of clinical signs and symptoms and traditional microbiologic diagnostics for respiratory infections, blood biomarkers that correlate with the presence and extent of bacterial infections may provide additional useful information to improve diagnostic and prognostic efforts and help with therapeutic decisions in individual patients. A growing body of evidence supports the use of procalcitonin (PCT) to differentiate bacterial from viral respiratory diagnoses, to help risk stratify patients, and to guide antibiotic therapy decisions about initial need for, and optimal duration of, therapy. Although still relatively new on the clinical frontier, a series of randomized controlled trials have evaluated PCT protocols for antibiotic-related decision making and have included patients from different clinical settings and with different severities of respiratory infection. In these trials, initial PCT levels were effective in guiding decisions about the initiation of antibiotic therapy in lower-acuity patients, and subsequent measurements were effective for guiding duration of therapy in higher-acuity patients, without apparent harmful effects. Recent European respiratory infection guidelines now also recognize this concept. As with any other laboratory test, PCT should not be used on a stand-alone basis. Rather, it must be integrated into clinical protocols, together with clinical, microbiologic data and with results from clinical risk scores. The aim of this review is to summarize recent evidence about the usefulness of PCT in patients with lower respiratory tract infections and to discuss the potential benefits and limitations of this marker when used for clinical decision making.",2012,10.1378/chest.11-2430,141,4,1063-1073,eng,1931-3543 0012-3692,Humans and Cost-Benefit Analysis and Prognosis and Costs and Cost Analysis and Anti-Bacterial Agents/therapeutic use and Biomarkers/blood and Calcitonin Gene-Related Peptide and Bacterial Infections/diagnosis/drug therapy and Calcitonin/*blood and Protein Precursors/*blood and Respiratory Tract Infections/drug therapy/economics/*microbiology and Virus Diseases/diagnosis/drug therapy,NA,NA,2012/04//undefined,Chest,NA,NA,NA,NA
Khakban_2015_Ches,JOUR,Ten-Year Trends in Direct Costs of COPD: A Population-Based Study,"Khakban, Amir and Sin, Don D. and FitzGerald, J. Mark and Ng, Raymond and Zafari, Zafar and McManus, Bruce and Hollander, Zsuzsanna and Marra, Carlo A. and Sadatsafavi, Mohsen",Chest,"BACKGROUND: Up-to-date estimates of burden of diseases are required for evidence-based decision-making. The objectives of this study were to determine the excess costs of COPD and its trend from 2001 to 2010 in British Columbia, Canada. METHODS: We used British Columbia's administrative health data to construct a cohort of patients with COPD and a matched comparison cohort of subjects without COPD. We followed each patient from the time of first COPD-related health-care event (or equivalent time for the comparison cohort). Direct medical costs (in 2010 Canadian dollars [$]) were calculated based on billing records pertaining to hospital admissions, outpatient services use, medication dispensations, and community care services. We determined the excess medical costs of COPD by calculating the difference in overall medical costs between the COPD and the comparison cohorts. RESULTS: The COPD and comparison cohorts comprised 153,570 and 246,801 people, respectively (for both cohorts, mean age at entry was 66.9 years; 47.2% female patients). The excess costs of COPD during the study period were $5,452 per patient-year. Inpatient, outpatient, medication, and community care costs were responsible for 57%, 16%, 22%, and 5% of the excess costs, respectively. Excess costs increased by $296/person-y (P < .01), with hospital costs demonstrating the largest increase over time ($258/person-y; P < .01). CONCLUSIONS: The direct economic burden of COPD is high and has increased significantly between 2001 and 2010 over and above the increase in the health-care costs of the general population. Further investigation is required to elucidate the underlying reasons for the temporal increase in COPD direct costs.",2015,10.1378/chest.15-0721,148,3,640-646,eng,1931-3543 0012-3692,"Humans and Female and Male and Middle Aged and Aged and Time Factors and Cohort Studies and Health Care Costs/*trends and British Columbia/epidemiology and Pulmonary Disease, Chronic Obstructive/*economics/epidemiology",NA,NA,2015/09//undefined,Chest,NA,NA,NA,NA
Meyer_2015_Ches,JOUR,Management of Idiopathic Pulmonary Fibrosis in the Elderly Patient: Addressing Key Questions,"Meyer, Keith C. and Danoff, Sonye K. and Lancaster, Lisa H. and Nathan, Steven D.",Chest,"Idiopathic pulmonary fibrosis (IPF) is strongly associated with advanced age. Making an accurate diagnosis of IPF is critical, as it remains only one of many potential diagnoses for an elderly patient with newly recognized interstitial lung disease. Optimal management of IPF, especially in older-aged patients, hinges on such factors as balancing the application of standard-of-care measures with the patient's overall health status (robustness vs frailty) and considering the patient's wishes, desires, and expectations. IPF is known to be associated with certain comorbidities that tend to be more prevalent in the elderly population. Until recently, options for the pharmacologic management of IPF were limited and included therapies such as immunosuppressive agents, which may pose substantial risk to the elderly patient. However, the antifibrotic agents pirfenidone and nintedanib have now become commercially available in the United States for the treatment of IPF. The monitoring and treatment of patients with IPF, especially elderly patients with comorbid medical conditions, require consideration of adverse side effects, the avoidance of potential drug-drug interactions, treatment of comorbidities, and the timely implementation of supportive and palliative measures. Individualized counseling to guide decision-making and enhance quality of life is also integral to optimal management of the elderly patient with IPF.",2015,10.1378/chest.14-2475,148,1,242-252,eng,1931-3543 0012-3692,Humans and Patient-Centered Care and Aged and Prognosis and Age Factors and Precision Medicine and Antineoplastic Agents/therapeutic use and *Disease Management and Idiopathic Pulmonary Fibrosis/complications/*diagnosis/*therapy and Indoles/therapeutic use and Pyridones/therapeutic use,NA,NA,2015/07//undefined,Chest,NA,NA,NA,NA
Chen_2021_Ches,JOUR,Corticosteroid Therapy Is Associated With Improved Outcome in Critically Ill Patients With COVID-19 With Hyperinflammatory Phenotype,"Chen, Hui and Xie, Jianfeng and Su, Nan and Wang, Jun and Sun, Qin and Li, Shusheng and Jin, Jun and Zhou, Jing and Mo, Min and Wei, Yao and Chao, Yali and Hu, Weiwei and Du, Bin and Qiu, Haibo",Chest,"BACKGROUND: Corticosteroid therapy is used commonly in patients with COVID-19, although its impact on outcomes and which patients could benefit from corticosteroid therapy are uncertain. RESEARCH QUESTION: Are clinical phenotypes of COVID-19 associated with differential response to corticosteroid therapy? STUDY DESIGN AND METHODS: Critically ill patients with COVID-19 from Tongji Hospital treated between January and February 2020 were included, and the main exposure of interest was the administration of IV corticosteroids. The primary outcome was 28-day mortality. Marginal structural modeling was used to account for baseline and time-dependent confounders. An unsupervised machine learning approach was carried out to identify phenotypes of COVID-19. RESULTS: A total of 428 patients were included; 280 of 428 patients (65.4%) received corticosteroid therapy. The 28-day mortality was significantly higher in patients who received corticosteroid therapy than in those who did not (53.9% vs 19.6%; P < .0001). After marginal structural modeling, corticosteroid therapy was not associated significantly with 28-day mortality (hazard ratio [HR], 0.80; 95% CI, 0.54-1.18; P = .26). Our analysis identified two phenotypes of COVID-19, and compared with the hypoinflammatory phenotype, the hyperinflammatory phenotype was characterized by elevated levels of proinflammatory cytokines, higher Sequential Organ Failure Assessment scores, and higher rates of complications. Corticosteroid therapy was associated with a reduced 28-day mortality (HR, 0.45; 95% CI, 0.25-0.80; P = .0062) in patients with the hyperinflammatory phenotype. INTERPRETATION: For critically ill patients with COVID-19, corticosteroid therapy was not associated with 28-day mortality, but the use of corticosteroids showed significant survival benefits in patients with the hyperinflammatory phenotype.",2021,10.1016/j.chest.2020.11.050,159,5,1793-1802,eng,1931-3543 0012-3692,"SARS-CoV-2 and COVID-19 and Mortality and Humans and Female and Male and Middle Aged and Aged and Severity of Illness Index and Organ Dysfunction Scores and China/epidemiology and phenotype and Outcome and Process Assessment, Health Care and Adrenal Cortex Hormones/*therapeutic use and *COVID-19/complications/immunology/mortality/therapy and *Critical Illness/mortality/therapy and *Inflammation/mortality/therapy and corticosteroid and Critical Care/methods/statistics & numerical data",NA,NA,2021/05//undefined,Chest,NA,NA,NA,NA
Lamb_2020_Ches,JOUR,Use of Tracheostomy During the COVID-19 Pandemic: American College of Chest Physicians/American Association for Bronchology and Interventional Pulmonology/Association of Interventional Pulmonology Program Directors Expert Panel Report,"Lamb, Carla R. and Desai, Neeraj R. and Angel, Luis and Chaddha, Udit and Sachdeva, Ashutosh and Sethi, Sonali and Bencheqroun, Hassan and Mehta, Hiren and Akulian, Jason and Argento, A. Christine and Diaz-Mendoza, Javier and Musani, Ali and Murgu, Septimiu",Chest,"BACKGROUND: The role of tracheostomy during the coronavirus disease 2019 (COVID-19) pandemic remains unknown. The goal of this consensus statement is to examine the current evidence for performing tracheostomy in patients with respiratory failure from COVID-19 and offer guidance to physicians on the preparation, timing, and technique while minimizing the risk of infection to health care workers (HCWs). METHODS: A panel including intensivists and interventional pulmonologists from three professional societies representing 13 institutions with experience in managing patients with COVID-19 across a spectrum of health-care environments developed key clinical questions addressing specific topics on tracheostomy in COVID-19. A systematic review of the literature and an established modified Delphi consensus methodology were applied to provide a reliable evidence-based consensus statement and expert panel report. RESULTS: Eight key questions, corresponding to 14 decision points, were rated by the panel. The results were aggregated, resulting in eight main recommendations and five additional remarks intended to guide health-care providers in the decision-making process pertinent to tracheostomy in patients with COVID-19-related respiratory failure. CONCLUSION: This panel suggests performing tracheostomy in patients expected to require prolonged mechanical ventilation. A specific timing of tracheostomy cannot be recommended. There is no evidence for routine repeat reverse transcription polymerase chain reaction testing in patients with confirmed COVID-19 evaluated for tracheostomy. To reduce the risk of infection in HCWs, we recommend performing the procedure using techniques that minimize aerosolization while wearing enhanced personal protective equipment. The recommendations presented in this statement may change as more experience is gained during this pandemic.",2020,10.1016/j.chest.2020.05.571,158,4,1499-1514,eng,1931-3543 0012-3692,"SARS-CoV-2 and COVID-19 and Humans and Pandemics and Consensus and Societies, Medical and Patient Selection and Clinical Protocols and *Betacoronavirus and Infectious Disease Transmission, Patient-to-Professional/*prevention & control and tracheostomy and *Tracheostomy and aerosol generating procedure and Coronavirus Infections/complications/*therapy/transmission and open surgical tracheostomy and percutaneous dilatational tracheostomy and Pneumonia, Viral/complications/*therapy/transmission and Respiratory Insufficiency/*therapy/virology",NA,NA,2020/10//undefined,Chest,NA,NA,NA,NA
Verdial_2020_Ches,JOUR,Multidisciplinary Team-Based Management of Incidentally Detected Lung Nodules,"Verdial, Francys C. and Madtes, David K. and Cheng, Guang-Shing and Pipavath, Sudhakar and Kim, Richard and Hubbard, Jesse J. and Zadworny, Megan and Wood, Douglas E. and Farjah, Farhood",Chest,"BACKGROUND: Each year, > 1.5 million Americans are diagnosed with an incidentally detected lung nodule. Practice guidelines attempt to balance the benefit of early detection of lung cancer with the risks of diagnostic testing, but adherence to guidelines is low. The goal of this study was to determine guideline adherence rates in the setting of a multidisciplinary nodule clinic and describe reasons for nonadherence as well as associated outcomes. METHODS: This cohort study included 3 years of follow-up of patients aged <e2><89><a5> 35 years with an incidentally detected lung nodule evaluated in a multidisciplinary clinic that used the 2005 Fleischner Society Guidelines. RESULTS: Among 113 patients, 67% (95% CI, 58-76) were recommended a guideline-concordant nodule evaluation; 7.1% (95% CI, 3.1-13) and 26% (95% CI, 18-25) were recommended less or more intense evaluation, respectively. In contrast, 58% (95% CI, 48-67), 22% (95% CI, 18-25), and 23% (95% CI, 16-32) received a guideline-concordant, less intense, or more intense evaluation. The most common reason for recommending guideline-discordant care was concern for two different diagnoses that would each benefit from early detection and treatment. A majority of lung cancer diagnoses (88%) occurred in patients who received guideline-concordant care. There were no lung cancer cases in those who received less intense nodule care. CONCLUSIONS: A multidisciplinary nodule clinic may serve as a system-level intervention to promote guideline-concordant care, while also providing a multidisciplinary basis by which to deviate from guidelines to address the needs of a heterogeneous patient population.",2020,10.1016/j.chest.2019.11.032,157,4,985-993,eng,1931-3543 0012-3692,Humans and Female and Male and Middle Aged and Risk Assessment and Patient Care Team and guidelines and Cohort Studies and Practice Guidelines as Topic and Health Services Needs and Demand and clinical decision-making and United States/epidemiology and Guideline Adherence/*statistics & numerical data and Incidental Findings and Lung Neoplasms/*diagnosis and *Early Detection of Cancer/methods/statistics & numerical data and *Solitary Pulmonary Nodule/diagnosis/epidemiology and Early Medical Intervention/statistics & numerical data and lung neoplasm and lung nodule,NA,NA,2020/04//undefined,Chest,NA,NA,NA,NA
Chen_2008_Ches,JOUR,Effect of decisions to withhold life support on prolonged survival,"Chen, Yen-Yuan and Connors, Alfred F. Jr and Garland, Allan",Chest,"BACKGROUND: The effect on long-term mortality of decisions made to withhold life-supporting therapies (LST) for critically ill patients is unclear. We hypothesized that mortality 60 days after ICU admission is not influenced by a decision to withhold use of LST in the context of otherwise providing all indicated care. METHODS: We studied 2,211 consecutive, initial admissions to the adult, medical ICU of a university-affiliated teaching hospital. To achieve balanced groups for comparing outcomes, we created a multivariable regression model for the probability (propensity score [PS]) of having an order initiated in the ICU to withhold LST. Each of the 201 patients with such an order was matched to the patient without such an order having the closest PS; mortality rates were compared between the matched pairs. Cox survival analysis was performed to extend the main analysis. RESULTS: The matched pairs were well balanced with respect to all of the potentially confounding variables. Sixty days after ICU admission, 50.5% of patients who had an order initiated in the ICU to withhold life support had died, compared to 25.8% of those lacking such orders (risk ratio, 2.0; 95% confidence interval, 1.5 to 2.6). Survival analysis indicated that the difference in mortality between the two groups continued to increase for approximately 1 year. CONCLUSION: Contrary to our hypothesis, decisions made in the ICU to withhold LST were associated with increased mortality rate to at least 60 days after ICU admission.",2008,10.1378/chest.07-1500,133,6,1312-1318,eng,0012-3692,Humans and Female and Male and Retrospective Studies and Aged and Time Factors and Intensive Care Units/*statistics & numerical data and APACHE and *Decision Making and *Survival Analysis and Glasgow Coma Scale and Resuscitation Orders and Withholding Treatment/*statistics & numerical data and *Life Support Care and Critical Illness/classification/*mortality,NA,NA,2008/06//undefined,Chest,NA,NA,NA,NA
Nickel_2019_Ches,JOUR,Mobility Identifies Acutely Ill Patients at Low Risk of In-Hospital Mortality: A Prospective Multicenter Study,"Nickel, Christian H. and Kellett, John and Nieves Ortega, Ricardo and Lyngholm, Le and Wasingya-Kasereka, Lucien and Brabrand, Mikkel",Chest,"BACKGROUND: A retrospective study has reported that impaired mobility on presentation (IMOP) enhanced the ability of vital signs to predict mortality in acutely ill patients. This study was designed to further examine the association between IMOP and in-hospital mortality. METHODS: Prospective observational study of three different cohorts of acutely ill patients admitted to hospitals in Esbjerg, Denmark (998 patients), Basel, Switzerland (743 patients), and Kitovu, Uganda (1,622 patients). RESULTS: There were significant differences in age, sex, length of stay, proportion of medical and surgical patients, and in-hospital mortality between the three cohorts. Yet in all three cohorts a National Early Warning Score (NEWS) <e2><89><a5> 3 when first recorded and IMOP increased the risk of in-hospital mortality to approximately the same extent. IMOP and NEWS <e2><89><a5> 3 when first recorded were, therefore, used for risk categorization: patients with a NEWS < 3 when first recorded and normal mobility on presentation had the lowest in-hospital mortality risk and those with NEWS <e2><89><a5> 3 when first recorded and IMOP had the highest risk. The number of these low risk patients ranged from 26% in Kitovu to 42% in Esbjerg, and their in-hospital mortality rates did not significantly differ in all three cohorts, ranging from 0.2% in Esbjerg to 0.4% in Basel. CONCLUSIONS: In this prospective multicenter study IMOP enhanced the risk categorization of acutely ill patients from very different clinical settings. The combination normal mobility on presentation and first recorded NEWS identified a substantial proportion of patients in all cohorts with a low risk of dying while in hospital. TRIAL REGISTRY: The Esbjerg data were collected as part of a trial registered with the US National Library of Medicine (ClinicalTrials.gov; No.: NCT03108807; URL: www.clinicaltrials.gov).",2019,10.1016/j.chest.2019.04.001,156,2,316-322,eng,1931-3543 0012-3692,"Denmark and Hospitalization and Humans and Female and Male and Adolescent and Adult and Middle Aged and Young Adult and Risk Assessment and Aged and Hospital Mortality and risk assessment and Prospective Studies and clinical decision making and Aged, 80 and over and Switzerland and Patient Acuity and Uganda and frailty and mobility and vital signs and *Mobility Limitation and Acute Disease/*mortality and early warning scores",NA,NA,2019/08//undefined,Chest,NA,NA,NA,NA
Golden_2015_Ches,JOUR,Primary Care Providers and a System Problem: A Qualitative Study of Clinicians Caring for Patients With Incidental Pulmonary Nodules,"Golden, Sara E. and Wiener, Renda Soylemez and Sullivan, Donald and Ganzini, Linda and Slatore, Christopher G.",Chest,"BACKGROUND: As lung cancer screening with low-dose CT scanning is implemented, an increasing number of people will be diagnosed with pulmonary nodules. Primary care clinicians care for the vast majority of these patients, but their experiences with communication and managing distress in this population are not well understood. METHODS: We conducted qualitative interviews of 15 primary care providers (PCPs) at two academic medical centers who care for patients with pulmonary nodules. We used qualitative description analysis, focusing on clinicians' information exchange and other communication behaviors. RESULTS: Most PCPs believed they had inadequate information to counsel patients regarding lung nodules, although this information is desired. PCPs were concerned patients could ""fall through the cracks"" but did not have access to a reliable system to ensure follow-up adherence. They were limited by time, knowledge, and resources in providing the preferred level of care. Most PCPs did not discuss the specific risk a nodule was lung cancer, in part because they did not have ready access to this information. PCPs believed most patients did not have substantial distress as a result of nodule detection. Most PCPs did not include patients when making decisions about the follow-up plan. CONCLUSIONS: PCPs often lack systemic resources to optimize patient-centered approaches when discussing incidental pulmonary nodules with patients. With the advent of lung cancer screening, pulmonologists can assist primary care colleagues by providing accurate information to counsel patients and assisting in managing conversations about the risk of cancer. Pulmonologists should support efforts to implement reliable systems to ensure adherence to follow-up.",2015,10.1378/chest.14-2938,148,6,1422-1429,eng,1931-3543 0012-3692,"Humans and Physician-Patient Relations and Communication Barriers and Needs Assessment and Qualitative Research and Attitude of Health Personnel and Clinical Decision-Making and Patient-Centered Care/methods/standards and Incidental Findings and *Lung Neoplasms/diagnosis/psychology and *Multiple Pulmonary Nodules/diagnosis/psychology and *Physicians, Primary Care/psychology/standards and *Solitary Pulmonary Nodule/diagnosis/psychology",NA,NA,2015/12//undefined,Chest,NA,NA,NA,NA
Apostolakis_2013_Ches,JOUR,Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TTR score,"Apostolakis, Stavros and Sullivan, Renee M. and Olshansky, Brian and Lip, Gregory Y. H.",Chest,"BACKGROUND: When oral anticoagulation with adjusted-dose vitamin K antagonist (VKA) is used, the quality of anticoagulation control (as reflected by the time in therapeutic range [TTR] of the international normalized ratio [INR]) is an important determinant of thromboembolism and bleeding. Our objective was to derive a validated scheme using patient-related clinical parameters to assess the likelihood of poor INR control among patients with atrial fibrillation (AF) on VKA therapy. METHODS: The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) trial population was randomly divided into derivation and internal validation cohorts using a 1:1 ratio. We used linear regression analysis to detect the clinical factors associated with TTR and binary logistic regression to evaluate the predictive performance of a model incorporating these factors for different cutoff values of TTR. The derived model was validated externally in a cohort of patients receiving anticoagulant therapy who were recruited prospectively. RESULTS: In the linear regression model, nine variables emerged as independent predictors of TTR: female sex (P < .0001), age < 50 years (P < .0001), age 50 to 60 years (P = .02), ethnic minority status (P < .0001), smoking (P = .03), more than two comorbidities (P < .0001), and being treated with a <ce><b2>-blocker (P = .02), verapamil (P = .02), or, inversely, with amiodarone (P = .05). We incorporated these factors into a simple clinical prediction scheme with the acronym SAMe-TT<e2><82><82>R (sex female, age < 60 years, medical history [more than two comorbidities], treatment [interacting drugs, eg, amiodarone for rhythm control], tobacco use [doubled], race [doubled]). The score demonstrated good discrimination performance in both the internal and external validation cohorts (c-index, 0.72; 95% CI, 0.64-0.795; and c-index, 0.7; 95% CI, 0.57-0.82, respectively). CONCLUSIONS: Common clinical and demographic factors can influence the quality of oral anticoagulation. We incorporated these factors into a simple score (SAMe-TT<e2><82><82>R<e2><82><82>) that can predict poor INR control and aid decision-making by identifying those patients with AF who would do well on VKA (SAMe-TT<e2><82><82>R<e2><82><82> score = 0-1), or conversely, those who require additional interventions to achieve acceptable anticoagulation control (SAMe-TT<e2><82><82>R<e2><82><82> score <e2><89><a5> 2).",2013,10.1378/chest.13-0054,144,5,1555-1563,eng,1931-3543 0012-3692,"Humans and Female and Male and Middle Aged and Aged and Prospective Studies and Treatment Outcome and Follow-Up Studies and Dose-Response Relationship, Drug and Administration, Oral and Electrocardiography and *Quality Indicators, Health Care and Anticoagulants/administration & dosage and Atrial Fibrillation/*complications/physiopathology and Blood Coagulation/drug effects and Stroke/blood/etiology/*prevention & control and Warfarin/*administration & dosage",NA,NA,2013/11//undefined,Chest,NA,NA,NA,NA
